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Summary
The research activity conducted during my PhD aims to develop two different Computer
Aided Diagnosis (CAD) systems for breast and prostate cancer diagnosis using Magnetic
Resonance Imaging.
During the first part of this thesis I will illustrate a fully automatic CAD system for
breast cancer detection and diagnosis with Dynamic Contrast Enhanced MRI (DCE-MRI)
developed by our group. The main goal of a CAD system is lesions detection and char-
acterization. The processing pipeline includes automatic segmentation of the breast and
axillary regions, registration of unenhanced and contrast-enhanced frames, lesion detec-
tion and classification according to kinetic and morphological criteria. During my PhD
I, firstly, studied the physiological phenomena correlated to breast tumors growth and
diagnosis, then I elaborated and created C++ algorithms for:
1. breasts segmentation, where the breasts and axillary regions are automatically iden-
tified in order to reduce the computational burden and preventing false positives
(FP) due to enhancing structures (such as the heart and extra-breast vessels) which
are not of clinical interest.
2. lesion detection, in which suspicious areas showing contrast enhancement are auto-
matically segmented and FPs are identified and discarded.
These step are innovative as they are fully automatic, thus they do not suffer of inter-
and intra-operator variability, and because of the normalization process, based on the
mammary arteries segmentation, that makes the system able to deal with images coming
from different centers, thus having different acquisition parameters. This work is being
performed in collaboration with the Institute for Cancer Research and Treatment (IRCC)
of Candiolo (MD Daniele Regge), and with i-m3D S.p.A., which designs, develops, produces
and markets medical devices intended for early diagnosis in medical imaging. Thanks to the
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contribution of i-m3D, I could register a patent based on these algorithms called “Method
and system for the automatic recognition of lesions in a set of breast magnetic resonance
images”.
The second part of my thesis will concern the development of a CAD system for prostate
cancer. The importance of this project is associated to the recent interest in adapting
focal methods of tissue ablation, such as cryotherapy and Focused Ultrasound guided by
MR (MRgFUS), to cure or control localized prostate cancer. Focal treatments rely on
imaging to locate tumor, to determine the staging of disease, to detect recurrences and
to guide the treatment. The aim of this part of my PhD was to create a multispectral
computer aided diagnosis system able to: a) detect the tumor in order to guide real-time
biopsy, b) characterize the malignancy of the lesion and c) guide the local treatment,
by adopting a new multispectral approach. In this project I, actively, elaborated and
developed C++ algorithm to register different datasets and to monitor the focal treatment
using Diffusion Weighted-MRI (DWI) self-made acquisitions.The registration between T2-
w, DCE-MRI and DWI images are applied in order to correct for patients movements and
DWI distortions. Results obtained within 19 patients showed a Dice’s overlap coefficient
higher than 0.7, considered optimal in literature.
Monitoring the focal therapy was the aim of the last part of this project, that I actively
developed during a visiting period in the Radiological Science Laboratory of the Stanford
University (Kim Butts Pauly Research Lab). The main goal was to characterize the role of
the DWI during MRgFUS. DWI, in fact, is very sensitive to cell death and tissue damage
and information can be used to evaluate the treatment without relocating the patient and
the applicators and without involving the administration of contrast agent. In this study,
I wanted to assess the use of DWI images to estimate prostate tissue damage during HIFU
ablation, by measuring diffusion coefficients of canine prostate pre and post ablation, using
multiple b-factors ranging up to 3500 s/mm2. This study demonstrated a bi-exponential
decay of the signal increasing the b-values suggesting the presence of two different type of
diffusion, called fast and slow.
In conclusion, during my PhD, I obtained the following original and novel goals:
a. I actively contributed to develop a fully automatic CAD system for breast cancer
diagnosis able to deal with images coming from different center. This goal is inno-
vative because in literature there are few methods completely automatic, and they
work only with MRI dataset acquired without fat-saturation. Fat-saturation has
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been introduced to enhance the contrast between lesion and surrounding tissue and
to overcome the limitations due to subtraction artifacts, however, it introduces ad-
ditional challenges for breast lesion segmentation, especially due to the lower signal-
to-noise-ratio (SNR) within the breasts.
b. I developed a CAD system to detect and diagnose prostate cancer, that uses the novel
approach of a multispectral analysis, that is the combinations of parameters coming
from different datasets (i.e. DWI, DCE, T2-weighted sequences). The multispectral
approach is able to improve the sensibility of the system, but makes the analysis
more complex, even for the experienced radiologist.
c. I elaborated a new method to monitor focal treatment of the prostate cancer, us-
ing DWI sequences, therefore, conversely to the gold standard used for this scope
(contrast enhanced MRI), without the administration of a contrast agent.
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Chapter 1
Introduction
Computer Aided Diagnosis (CAD) systems are playing an increasingly important role in
medical diagnosis, with a wide variety being proposed within the last decade [1, 2, 3, 4, 5].
The main idea of a CAD systems is to assist radiologists in interpreting medical images
by using dedicated computer systems to provide a “second opinions”. Studies on CAD
systems show that CAD can help to improve diagnostic accuracy of radiologists, lighten
the burden of increasing workload, reduce cancer missed due to fatigue, overlooked or data
overloaded and improve inter- and intra-reader variability. Two typical and widely used
examples of application of CAD in clinical areas are the use of computerized systems in
mammography for breast cancer screening and for the early diagnosis of lung cancer with
computed tomography (CT) scans. In this work CAD systems have been developed to
cope with problems related to early diagnosis of two common tumors: breast cancer which
is the second most common malignancy after lung cancer and the most common cancer
in women [6, 7], and prostate cancer, the most common malignancy affecting men in the
world, representing the third cause of cancer death in industrialized countries [8, 9, 10].
Magnetic Resonance Imaging (MRI) has been chosen as imaging modalities because of its
intrinsic high soft tissue resolution. However different MR sequences could be used, accord-
ing to the aim of the exam and the type of tumor. For breast cancer diagnosis, Dynamic
Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) is increasingly used as an
adjunct to conventional imaging techniques (mammography and sonography) [11]. It relies
on signal enhancement after the intravenous injection of a two-compartment gadolinium-
based paramagnetic contrast agent: the intensity increases with the concentration of the
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contrast agent as it perfuses the tumoral vasculature and diffuses in the extravascular extra-
cellular space. As many image volumes are collected during DCE-MRI exam, the diagnosis
is time consuming and could suffer from a high inter- intra observer variability. For this
reason a fully automatic CAD system, that aids in the visualization of kinetic information
by providing a color map based on the kinetic information, that facilitates analysis through
graphical and quantitative representations and provides an index of suspicion, has been
developed.
For prostate cancer diagnosis in addition to DCE-MRI imaging, generally, T2-weighted
(T2-w) are used to allow a clear visualization of the prostate anatomy; the central lobe
can be easily distinguished from the periphery of the gland and the capsule is clearly
discernible as a thin dark linear structure. Moreover, Magnetic Resonance Spectroscopy
(MRS) extends the possibilities to detect PCa by allowing assessment of molecular con-
stituents of the tissue, especially of choline, which is in higher concentration in tissue with
a high cellular metabolism [12]. Finally, Diffusion Weighted Imaging (DWI) can measure
the diffusion of water molecules in tissue and hence provide information on the structural
organization of the tissue. However, each MR approach alone has some drawbacks, which
can be implied from the large range of sensitivity and specificity variations reported in
literature, only partially explained by the different diagnostic criteria used in the various
study [12, 13]. Recently it has been shown that combining 2 or more MR modalities im-
proves the sensitivity by almost 15%, bringing it up to 83-87% for tumors measuring 5
cm3 or more [14]. However the more variables are introduced the more difficult is, even
for the experienced reader, to integrate all the available information into one reliable final
report. Complex problems, such as the one reported in the previous paragraph, have been
approached by developing a CAD scheme that aid the radiologist in diagnosing disease.
2
Chapter 2
Angiogenesis and hemodynamic
parameters
2.1 Angiogenesis and cancer
Angiogenesis is a crucial mechanism required for a number of physiological and patholog-
ical events. In physiological conditions, angiogenesis is a highly regulated phenomenon,
while it is unregulated in pathological conditions, such as psoriasis, diabetic retinopathy
and cancer [15]. In physiologic conditions, cells are located within 100 and 200 µm from
blood vessels, their source of oxygen, and when a multicellular organism is growing, cells
induce angiogenesis and vasculogenesis in order to recruit new blood supply. In the same
way, in a pathological condition such as cancer, angiogenesis performs a critical role in the
development, survival and proliferation of the tumor. Solid tumors smaller than 1 to 2
cubic millimeters are not vascularized, and to spread, they need to be supplied by blood
vessels that bring oxygen and nutrients and remove metabolic wastes. Beyond the criti-
cal volume of 2 cubic millimeters, oxygen and nutrients hardly diffuse to the cells in the
center of the tumor, causing a state of cellular hypoxia that marks the onset of tumoral
angiogenesis.
New blood vessel development is an important process in tumor progression. It favors the
transition from hyperplasia to neoplasia, i.e., the passage from a state of cellular multiplica-
tion to a state of uncontrolled proliferation characteristic of tumor cells. Neovascularization
also influences the dissemination of cancer cells throughout the entire body eventually lead-
ing to metastasis formation. The vascularization level of a solid tumor is thought to be an
3
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excellent indicator of its metastatic potential.
2.2 The role of hypoxia
Hypoxia arises early in the process of tumor development because rapidly proliferating
tumor cells outgrow the capacity of the host vasculature. Tumors with low oxygenation
have a poor prognosis, and strong evidence suggests that this is because of the effects of
hypoxia on malignant progression, angiogenesis, metastasis, and therapy resistance. Tumor
cells located more than 100 µm away from blood vessels become hypoxic, some clones will
survive by activating an angiogenic pathway. If new blood vessels do not form, tumor clones
will be confined within 1-1.5 mm diameter. Such clones can remain dormant from months
to years before they switch to an angiogenic phenotype. Vascular cooption is confined only
in the tumor periphery and gradual tumor expansion causes a progressive central hypoxia.
Hypoxia induces the expression of pro-angiogenic factors through hypoxia-inducible factor
and, if pro-angiogenic factors are in excess of anti-angiogenic factors, it may lead to the
switch to an angiogenic phenotype. The presence of viable hypoxic cells is likely a reflection
of the development of hypoxia tolerance resulting from modulation of cell death in the
microenvironment. This acquired phenotype has been explained on the basis of clonal
selection. The hypoxic microenvironment selects cells capable of surviving in the absence
of normal oxygen availability.
However, the persistence and frequency of hypoxia in solid tumors raise a second potential
explanation. It has also been suggested that stable micro-regions of hypoxia may play a
positive role in tumor growth. Although hypoxia inhibits cell proliferation and eventually
causes cell death, hypoxia also provides angiogenic and metastatic signals, thus allowing
prolonged survival in the absence of oxygen and generation of a persistent angiogenic signal.
2.3 Mechanisms of new vessels formation
The first interest in angiogenesis related to cancer was in 1968, when it was first highlighted
that tumor secretes a diffusible substance that stimulates angiogenesis [16]. Since then,
several investigators studied the different pro-angiogenic factors that tumor cells diffuse
when the mass reaches the limited size of the early tumor. Pioneering studies performed
by Folkman in 1971 proposed an insightful anticancer therapy by starvation of blood supply
[17]. Folkman’s intuition that tumor growth and metastasis strictly depend on angiogenesis
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led to the idea that blocking tumor nourishment could be one of the ways to avoid its
spread.
The new vessels formation mechanisms could be distinguished into cellular and molecular.
2.3.1 Cellular mechanisms
Tumors can use four cellular mechanisms to acquire new blood vessels: co-option of pre-
existing vessels, angiogenesis, vasculogenesis and intussusception. Tumor cells can grow
along existing vessels without evoking an angiogenic response. This process was defined as
vessel co-option.
With tumor growth, cancer cells migrate along blood vessels, compressing and destabiliz-
ing them, which leads to vessel regression and reduced perfusion. This causes hypoxia and
tumor-cell death. Hypoxia and mutations in cancer cells induce the secretion of growth
factors that recruit new blood vessels through angiogenesis. Alternatively, in some cases
angiogenesis is driven by Vascular Endothelial Growth Factor (VEGF) through the accu-
mulation of a hypoxia-inducible factor in the absence of hypoxia.
Another mechanism by which tumors can acquire new vasculature is adult vasculogenesis
(vasculogenesis means the formation of a de novo vascular system from endothelial pre-
cursor cells). Although this process is incompletely understood and controversial, bone-
marrow-derived cells can enter blood circulation and contribute to vessels formation by
direct incorporation into functional vasculature.
Finally, a mechanism referred to as intussusception, in which tumor vessels remodel and
expand through the insertion of interstitial tissue columns into the lumen of pre-existing
vessels, has been seen in murine models of colon and lung cancer metastasis in the brain
[18].
2.3.2 Molecular mechanisms
Neovascularization of tumors could be driven by VEGF signalling through its endothelial
receptor. During sprouting angiogenesis, vessels initially dilate and become leaky as an
initial response to VEGF secreted by cancer or stromal cells. Angiopoietin 2 and certain
proteinases mediate the dissolution of the existing basement membrane and interstitial
matrix by acting in concert with VEGF. Numerous molecules stimulate endothelial prolif-
eration, migration and assembly into vascular networks. Although VEGF and its receptor
are currently the main targets for anti-angiogenic agents developed for cancer therapy,
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Figure 2.1. Schematic representation of the mechanisms of vessel formation and the asso-
ciated molecular components (in the case of brain tumor). Normal blood vessels are typically
composed of three cell types: endothelial cells, pericytes and astrocytes (a). Tumors can use
four mechanisms to acquire new blood vessels: co-option, angiogenesis, vasculogenesis and
intussusception (not shown). When tumor cells colonize the brain, whether from a distant
site (metastasis) or locally, they initially infiltrate along the blood vessels and white-mat-
ter tracts (factors, cells and receptors that contribute to cell tumor invasion, upregulation
of VEGF and increase of the tumor vascular supply are depicted in blue, yellow and pur-
ple)(b). The co-option of the normal brain capillaries (c) provides the invading tumor cells
with oxygen and nutrients. Angiopoietin 1 (ANG1, in green) maintains vessel integrity.
ANG2 (in red) - produced by tumor or endothelial cells - can bind to a receptor on endothe-
lial cells and destabilize the vessels. As the tumor grows, cancer cells migrate along blood
vessels, compressing and destabilizing them, leading to vessel regression and reduced perfu-
sion. This causes hypoxia and even tumor cell death. Hypoxia and mutations in cancer cells
induce the secretion of growth factors, such as vascular endothelial growth factor (VEGF),
that recruit new blood vessels through angiogenesis (d). In addition, platelet-derived growth
factor receptor (PDGF) can upregulate VEGF, and exert autocrine effects on endothelial
and perivascular cells. These molecules can also induce vasculogenesis, which is another
mechanism by which brain tumors may acquire new vasculature (e) [18].
the number of molecular players involved in tumor blood vessel survival and growth is
expanding.
2.4 Angiogenesis and metastases
Angiogenic primary tumors possess a large number of micro-vessels that can stimulate
metastatic activity, by carrying the metastasizing cells, increased 100-fold or more [19],
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through the blood stream to the other organs. The well-recognized hyper-permeability
of tumor vessels, tied to angiogenesis, may also contribute to the transendothelial escape
of tumor cells. New, proliferating capillaries have fragmented basement membranes that
partially account for this hyperpermeability. Having entered the circulation, the cells
must survive the journey, escape immune surveillance, penetrate (or grow from within) the
microvessels of the target organ, and again induce angiogenesis in the target in order to
grow beyond 2 mm in diameter. It is noteworthy that angiogenesis may not be sufficient,
in itself, for metastases to occur. However, the inhibition of angiogenesis prevents the
growth of tumor cells at both the primary and secondary sites and thereby can prevent the
emergence of metastases. Being a limiting factor for both tumor growth and metastases,
it has been assumed that angiogenesis correlates with tumor aggressiveness. Indeed, this
assumption has been supported in clinical series investigating a variety of tumor types.
Histological assays of angiogenesis based on the Microvascular Density (MVD), the number
of endothelial clusters in a high-power microscopic field, in randomly selected human breast
cancers showed that MVD correlated with the presence of metastases at time of diagnosis
and with decreased patient survival times. MVD is widely accepted as a measurable
surrogate of the angiogenesis process.
2.5 Tumor vasculature characterization
In mature (non-growing) capillaries, the vessel wall is composed by an endothelial cell
lining, a basement membrane, and a layer of cells called pericytes, which partially surround
the endothelium. The pericytes are contained within the same basement membrane as
the endothelial cells and occasionally make direct contact with them. Angiogenic factors
produced by tumoral cells bind to endothelial cell receptors and initiate the sequence of
angiogenesis. When the endothelial cells are stimulated to grow, they secrete proteases,
heparanase, and other digestive enzymes that digest the basement membrane surrounding
the vessel. Degradation of basement membrane and the extracellular matrix surrounding
preexisting capillaries, usually post-capillary venules, is a mechanism allowed by matrix
metalloproteinases, a family of metallo-endopeptidase secreted by the tumor cells and
the supporting cells. The dissolution of extracellular matrix also allows the release of pro-
angiogenic factors from the matrix. The junctions between endothelial cells become altered,
cell projections pass through the space created, and the newly formed sprout grows toward
the source of the stimulus. Endothelial cells invade the matrix and begin to migrate and
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proliferate into the tumor mass. In this location, newly formed endothelial cells organize
into hollow tubes (canalization) and create new basement membrane for vascular stability.
Fused blood vessels newly established form the blood flow within the tumor. The structure
of solid tumors is fundamentally chaotic, in contrast to the elegant and ordered anatomical
design of normal tissues and organs [20].
Tumor microcirculation highly differs from that of normal organs in different ways:
• flow characteristics and, sometimes, the blood volume of the microvasculature;
• microvascular permeability;
• for many malignant tumors, in the increased fractional volume of Extracellular Ex-
travascular Space (EES);
• increased interstitial fluid pressure (IFP).
The microvasculature is now known to be aberrant in many malignant tumors and in
leukemic bone marrow, because of tumor-derived factors that stimulate the endothelial
cells to form new small vessels (angiogenesis) and affect the maturation of these vessels
(vasculogenesis). The network of blood vessels in many solid tumors has been shown to
deviate markedly from normal hierarchical branching patterns and to contain gaps in which
tumor cells lack close contact with perfusing vessels. This phenomenon has been shown
in a variety of solid tumors to lead to blood flow that is both spatially and temporally
more heterogeneous than the efficient, uniform perfusion of normal organs and tissues. In
addition to these abnormalities, tumors often differ from the surrounding organ in the per-
meability (more properly, permeability × surface area product) of their capillaries. This
altered permeability is important in itself, because it changes the rules governing the trans-
fer of compounds between blood and tumor tissue.
Another abnormality, which specifically affects the trapping and clearance of agents in
tumors, is the marked alteration in relative volumes of major tissue compartments (vascu-
lar, intracellular, and extravascular-extracellular), with expansion of the EES distribution
volume. In cases of tissue injury or pathology, the fractional EES volume, ve, may increase
significantly.
In healthy tissues with normal microvascular perfusion and lymphatic drainage, the IFP is
close to zero mm Hg resulting in a positive transcapillary pressure gradient which favors ex-
travasation of the drugs from the capillaries into the interstitial space. In tumors, however,
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the increase in the capillary permeability and impaired lymphatic drainage augment IFP
to values ranging from 7 mm Hg to as high as 60 mm Hg thereby reducing, and at times
even eliminating, the positive transcapillary pressure gradient that cause extravasation of
solutes from the capillaries. Furthermore, the interstitial pressure gradient generated by
the high IFP in the tumor center as compared to the tumor periphery, causes outward
convection and reduced delivery to central regions [21].
Figure 2.2. Left: in health, an organized and efficient vascular supply. Right: tu-
mors produce angiogenic factors (various shades of green) that induce an abnormal,
inefficient vascular network [18].
Figure 2.3. Structural and functional differences between normal and tumor vascu-
lature. a) Photomicrograph of normal vasculature in mouse brain. The vasculature
is optimally organized, appropriately connected and shaped to provide nutrients to all
parenchymal cells. b) Photomicrograph of vasculature in a glioma xenografted into the
brain of an immunodeficient mouse (cancer cells shown in green). This vasculature
(vessels shown in red, red blood cells in blue) is disorganized, poorly connected and
tortuous, resulting in regions of hypoxia [18].
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Figure 2.4. Transport in tumors compared with normal tissue. In normal tissues, the
basal lamina and endothelial lining of tumor blood vessels allow extravasation of low-molec-
ular-weight (LMW) molecules (grey) either by convection (transmission of molecules by the
movement of the medium) or diffusion (spontaneous movement of molecules by random
thermal motion). However, extravasation of high-molecular-weight (HMW) macromolecules
and particulates (green) by convection or diffusion is normally prevented in most tissues;
this is indicated by the red cross in the right panel. In tumor tissues, the basal lamina and
endothelial lining of tumor blood vessels have a leaky morphology, allowing macromolecules
and particulates below a “pore ”cut-off size to pass through the vessel walls. After extravasa-
tion, these macromolecules and carriers become trapped within the tumor because increased
interstitial pressure, dysfunctional hydrodynamics and lack of lymphatic vessels reduce fluid
drainage and therefore reduce transport by convection (blue crosses in the right panel) rather
than by diffusion. Thus, transport beyond the blood vessels and in the tumor interstitium
depends largely on diffusion rather than convection. The efficiency of transport by diffusion
depends on the hydrodynamic radius and is therefore better for LMW drugs (as indicated
by the longer arrow for LMW molecules than HMW in the right panel). Interstitial trans-
port of large entities is further limited by spatial restrictions owing to the density of the
extracellular matrix. As a consequence, the tumor acts like a sieve that filters out suitable
carriers from the blood stream: this is the so-called enhanced permeability and retention
(EPR) effect. The tumor tissue is illustrated here with extra layers of cells, to represent the
longer diffusion distances that might need to be traversed. However, even for LMW drugs,
distribution throughout the tumor is not necessarily homogeneous and an equilibrium might
only be reached after extended periods of drug exposure.
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Imaging angiogenesis
Imaging of angiogenic vasculature may be a better alternative than measuring microvessel
density for assessing therapy because it is non invasive and can be used to assess much larger
volumes than biopsy samples. Several imaging methods have been developed to measure
blood volume and blood flow, as well as differences in blood vessel permeability, vascu-
lar size, and oxygenation. The modalities used to image angiogenic vasculature include
x-ray computed tomography (CT), Dynamic Contrast-Enhanced magnetic resonance imag-
ing (DCE-MRI), Diffusion Weighted Magnetic Resonance imaging (DWI-MRI), positron
emission tomography (PET), single-photon emission computed tomography (SPECT), ul-
trasound and and near-infrared optical imaging.
DWI, PET, SPECT and US are steady-state imaging methods: the contrast agent remains
confined within the vasculature at a constant concentration throughout the imaging pe-
riod, while DCE-MRI and dynamic CT are dynamic contrast imaging methods, in which
the contrast agent permeate the vascular endothelium and serial images are acquired as
the agent enters and leaves the tissue [22].
3.1 Computed Tomography
Dynamic or functional CT could be readily incorporated into routine conventional CT
examinations, and the physiological parameters obtained could provide an in vivo marker
of angiogenesis in tumors. Using this technique, it is possible to determine absolute values
for tissue perfusion, relative blood volume, capillary permeability, and leakage. These
parameters correlate with the microscopic changes that occur with tumor angiogenesis,
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characterized by an increased number of small blood vessels. These microvessels are too
small to be imaged directly, but their increased density leads to in vivo to an increased
tumor perfusion and blood volume. Dynamic CT has been used by various investigators
to evaluate tumor microvessels density.
Hemodynamic data from CT imaging may be more quantitative than data obtained by MRI
because the change in CT image intensity due to the contrast agent is linearly related to
the concentration of the contrast agent. In addition, CT has the highest spatial resolution
of all imaging modalities and dynamic CT is a simple, widely available and reproducible
technique.
However, the sensitivity of CT is limited, and high concentrations of CT contrast agent
are required, which can cause toxic effects. This toxicity, together with the relatively
high doses of radiation needed (because early clinical studies of antiangiogenic compounds
require multiple imaging assessments of the tumor), limits the use of CT for repeated
scanning [22].
3.2 Positron Emission Tomography and Single Photon Emis-
sion Computed Tomography
Both PET and SPECT imaging are highly quantitative and sensitive to very low concentra-
tions of tracer molecules. PET, which is able to detect picomolar concentrations of tracer,
is approximately 10 times more sensitive than SPECT. Both methods are well suited to
molecular imaging because of the generally low concentrations of target molecules, as well
as for gathering hemodynamic data. However, because the radionuclides used in PET trac-
ers have a very short half-life (2 minutes for 15O, 20 minutes for 11C, and 10 minutes for
13N), PET can only be performed at facilities that have a PET scanner and the necessary
cyclotron and chemical laboratory for the preparation of the tracers.
The radionuclides used for SPECT are easier to prepare and somewhat longer lived than
those used for PET (6 hours for 99mTc, 67 hours for 111In, and 13.2 hours for 123I), and
SPECT imaging is much more widely available than PET imaging. However, both PET
and SPECT images are of lower spatial resolution than magnetic resonance (MR) or CT
images [22].
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3.3 Ultrasound
Although ultrasound imaging is inexpensive, portable, and widely available, it produces
images that have low spatial resolution compared with those produced by MRI or CT. How-
ever, very low concentrations of micron-sized gas-filled microbubble contrast agents can be
detected by ultrasound, and these are useful agents for angiogenic imaging. Microbubbles
are true intravascular contrast agents and are useful for measuring blood volume and flow,
although the calculated values obtained by using these agents are not absolute but relative
to those in other tissues at similar depths [22].
3.4 Near-infrared spectroscopic
Optical technologies, such as near-infrared spectroscopic diffuse optical tomography and
orthogonal polarization spectroscopy, are being developed as alternative modalities for
imaging characteristics of angiogenic vasculature. Near-infrared light penetrates tissue
sufficiently well to obtain low-resolution images of tissues to a depth of a few centimeters,
and the regional concentration of hemoglobin and oxygen saturation can be calculated from
the absorption of hemoglobin and deoxyhemoglobin. Optical imaging has the advantage
of being relatively inexpensive and portable, but it is not yet widely available [22].
3.5 Dynamic Contrast Enhanced MRI
DCE-MRI is a non invasive technique that yields parameters related to tissue perfusion
and permeability, as it is performed during the administration of a paramagnetic contrast
agent (CA). The CA is injected as a rapid intravenous bolus and, passing through tissues,
it diffuses out of the blood vessels into the intravascular and extracellular fluid space
of the body. Tissues taking up such agents will become bright in a T1-weighted MRI
sequence [23] (see Chapter 4), making MRI very sensitive to the concentrations of CA
that permeate through capillary walls in angiogenic vasculature, and more reliable than
other imaging modalities for measuring parameters that are dependent on permeability.
DCE-MRI analysis, however, is time-consuming because multiple volumes are acquired,
and suffers from high inter-intra observer variability. A large range of techniques have
been applied to the analysis of the signal enhancement curves observed in DCE-MRI. An
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approach commonly used in clinical environments is based upon a subjective evaluation
of the time-signal intensity curve. Relative changes in semiquantitative parameters, such
as the maximum gradient of the signal-intensity-time curve, the maximum increase in
signal intensity normalized to baseline signal intensity (enhancement), and the area under
the initial part of the curve, can be examined and are indirectly related to changes in
the physiologic end points of interest: tissue perfusion, vascular permeability, and vessel
surface area. A review about the semiquantitative techniques can be found in Ref. [24],
chapt. 1.
One of the attractions of dynamic post contrast imaging is the potential insight it offers
into CA distribution kinetics in the tissue [25]. These quantities are generally derived from
simple models of the tissue as a compartmentalized system (usually a plasma-interstitial
two-compartments model is used), using of kinetic analysis strategies originally developed
for use with nuclear medicine tracers.
3.5.1 Semiquantitative and quantitative hemodynamic parameters
Several semiquantitative hemodynamic parameters have been derived from enhancement
curves acquired from dynamic contrast imaging. These parameters include the initial and
steepest slope of the curve, the time taken to reach 90% of the maximum enhancement
(change in intensity), and the maximum enhancement attained after injection of a bolus
of contrast agent. Prolonged changes in signals due to extravasation of contrast agent are
seen in both MRI and CT imaging, especially in the more permeable angiogenic vascula-
ture of tumors.
Because contrast agents used for CT and MRI pass through the vascular endothelium
but not cell membranes, effectively confining them to the plasma and the extracellular
extravascular space, a two-compartment model can be used to derive quantitative param-
eters linked to physiologic characteristics. Several quantitative hemodynamic parameters
have been established as standards [26]: Ktrans (min−1), the rate of contrast agent flux
into the extracellular extravascular space within a given volume, or volume transfer con-
stant; ve, the volume of the extracellular extravascular space; and kep (min−1), the rate
constant for the backflux from the extracellular extravascular space to the vasculature.
These parameters are related to each other by the equation:
kep =
Ktrans
ve
. (3.1)
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Ktrans has several physiologic interpretations, depending on the balance between capillary
permeability and blood flow. In situations in which capillary permeability is very high, the
flux of the contrast agent into the extravascular extracellular space is limited by the flow
rate. In this case, the kinetics follows the Kety model, and Ktrans is equal to the blood
plasma flow per unit volume of tissue.
When tracer flux is very low and blood flow is high, the blood plasma can be considered as
a single pool, in which the concentration of contrast agent does not change substantially
during the scan. Any change in signal is, therefore, due to the increase in the concentration
of the contrast agent in the extravascular extracellular space. In this case, Ktrans is equal to
the product of the permeability and the surface area of the capillary vascular endothelium
(i.e., Ktrans is equal to the permeability surface area).
If the passage of contrast agent across the vasculature endothelium is limited by blood flow
as well as by permeability, then the fractional reduction of capillary blood concentration
of the contrast agent as it passes through the tissue must be taken into account. The
rate of contrast agent flow out of the capillaries is initially high but decreases over time as
the backflow of the contrast agent increases. The rate of clearance of the contrast agent
from the system must also be accounted for by using a proportionality constant that links
the concentration of the contrast agent to the rate of elimination of the agent from a
compartment.
All of these situations fit into a generalized kinetic model, which can be expressed by the
equation:
dCt
dt
= Ktrans(
Cp − Ct
ve
) = KtransCp − kepCt, (3.2)
where Ct is the tracer concentration in tissue, Cp is the tracer concentration in plasma,
and t is time (in seconds) [22].
3.6 Diffusion Weighted MRI
A new, emerging functional technique that is now finding a role in cancer imaging is
diffusion-weighted MRI (DWI), which produces information about tissue cellularity and
the integrity of cellular membranes. DWI provides information on the random (Brownian)
motion of water molecules in tissues. The Brownian displacements of millions of water
molecules over time are normally distributed with a mean final value of zero for all time
periods measured, but with a standard deviation that is proportional to the diffusion coef-
ficient and time measured. This was the basis for Einstein’s diffusion equation published in
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Figure 3.1. Major compartments and functional variables involved in the distribution of
contrast agent in tissues.Ct is the tracer concentration in tissue, Cp is the tracer concen-
tration in the plasma and Ce is the tracer concentration in the EES (respectively in units
of mM). vp is the plasma volume fraction and ve is the EES fraction in a given volume
element of tissue. kep and kpe are the transport constants related to the leakage space in
units of min−1. Ktrans, defined as Ktrans = vekpe, defines, roughly speaking, the amplitude
of the initial response (the amount of tracers that enters the EES), while kpe determines the
washout rate from EES back into the blood plasma.
1905, which subsequently helped to earn him the 1921 Physics Nobel Prize. In tissues, DWI
probes the movement of water molecules, which occurs largely in the extracellular space.
However, the movement of water molecules in the extracellular space is not entirely free,
but is modified by interactions with hydrophobic cellular membranes and macromolecules
[27]. Hence, diffusion in biological tissue is often referred to as “apparent diffusion”. By
comparing differences in the apparent diffusion between tissues, tissue characterization be-
comes possible. For example, a tumor would exhibit more restricted apparent diffusion
compared with a cyst because intact cellular membranes in a tumor would hinder the free
movement of water molecules.
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Chapter 4
MRI sequences
4.1 MRI basics
The basic theoretical elements of a pulsed Nuclear Magnetic Resonance (NMR) experiment,
adopting a semi-classical approach, are synthetically introduced.
4.1.1 Spin and magnetic moment
Spin is an intrinsic property of elementary particles that was first observed in electrons. In
the 1880’s scientists studying the spectrum of light emitted by mercury vapor discovered
that light emitted by atoms was not a continuous range of frequencies but rather a discrete
one. As instruments measuring the emission spectra of various elements acquired more
and more resolving power, it was discovered that the discrete lines in the emission spectra
of alkali metals are themselves formed of a set of even finer lines. Just as the initial
coarser splitting of the emission spectra was due to the properties of the orbital angular
momentum of electrons around the nucleus, two Dutch physicists, Samuel Goudsmith
and George Uhlenbeck, attributed this new fine structure splitting to an intrinsic angular
momentum of the electron. The discovery of the further splitting of each component of
the spectra in even finer lines let Wolfgang Pauli propose the existence of the hyperfine
structure related to nuclear spin. The existence of nuclear spin was first demonstrated
in 1922 by the Stern Gerlach experiment, in which a beam of silver atoms were passed
through a magnetic field and split into two beams. The two beams represent two states,
up |↑〉 and down |↓〉, of the silver nuclei. The nuclear spin has an associated intrinsic
angular momentum, a vector represented by the symbol I. According to the Heisenberg
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uncertainty principle, we can know simultaneously the length of I, together with only one
of its components, conventionally assumed as the z-component, Iz :
| I |2= ~[I(I + 1)] (4.1)
Iz = ~m (4.2)
where ~ is Planck’s constant divided by 2pi, I is the spin quantum number and m is the
magnetic quantum number, taking the following set of values: m = (−I,−I+1, ..., I−1, I).
In the case of spin 1/2 nuclei (I = 1/2), like the two most abundant silver isotopes or 1H,
m can only be equal to -1/2 or 1/2. Nuclei having a spin angular momentum also have an
associated magnetic moment, µ, given by:
µ = γI (4.3)
µz = γIz = γ~m (4.4)
where Eqn. 4.2 has been exploited and γ is the gyromagnetic ratio (sometimes called the
magnetogyric ratio), an intrinsic property of each nucleus.
For a given abundance, nuclei with higher values of γ produce higher sensitivity NMR
spectra. In fact, 1H is the most commonly used isotope in magnetic resonance because of
his abundance and sensitivity (all over the document we assume to deal with 1H nuclei).
4.1.2 Effect of a static magnetic field
During an NMR experiment, the sample is placed into a static magnetic field, generally
referred to as B0. The energy of a magnetic moment immersed in B0 is given by:
E = −µ ·B0 (4.5)
The z reference axis is conventionally chosen along B0 and the magnitude of the field
(coinciding with its z component) is referred to as B0, i.e.,
B0 = B0k (4.6)
where k is the unit vector along z (in the following, unit vectors along x and y are referred
to as i and j, respectively). Substituting Eqn.s 4.6 and 4.4 in Eqn. 4.5, the energy of the
nuclear spins of the sample can be written as:
E = −µzB0 = −γIzB0 (4.7)
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or
Em = −mγ~B0 (4.8)
where Em is the energy of the spin state with the specific quantum number m.
In absence of field, the |↑〉 and |↓〉 states of a spin 1/2 system have the same energy and
are equally populated, leading to zero net magnetization. When samples are placed into
a magnetic field, a non-zero energy difference between the states (known as the Zeeman
splitting) develops:
∆E = E|↓〉 − E|↑〉 = γ~B0 (4.9)
where Eqn. 4.8 has been used. A small excess of nuclei fall into the lower energy |↑〉 state,
according to the Boltzmann distribution:
N|↑〉
N|↓〉
= exp(
∆E
kBT
) (4.10)
where kB is the Boltzmann’s constant, T is the absolute temperature and N|↑〉/N|↓〉 is the
ratio between the populations of the states. The difference in population between the spin
states, give rise to a non-null macroscopic magnetization vector, M , defined as the vector
sum of all the microscopic magnetic moments in the specimen:
M =
∑
i
µi (4.11)
where µi is the magnetic moment of the i -th nuclear spin, and the sum is performed over
all the spins in the sample.
The fractional population difference at equilibrium in a typical clinical setup (protons in
a magnetic field of 1.5 T at 300 K) is:
N|↑〉 −N|↓〉
N|↑〉 +N|↓〉
= 5× 10−6. (4.12)
This excess of spins accounts for the entire net magnetization measured in the NMR
experiment. This explains the relatively low sensitivity of MRI (only five protons in a
million can be measured) compared with imaging techniques involving radioactive isotopes,
where any single decay can be detected.
4.1.3 Magnetization and radio frequency pulses
From Planck’s law, ∆E = ~ν, and Eqn. 4.9, the frequency ν0 of an NMR transition in a
magnetic field B0 is:
ν0 =
∆E
h
=
γB0
2pi
(4.13)
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or, given ν0 = ω0/2pi,
ω0 = γB0 (4.14)
where ω0 is known as the Larmor precession frequency.
NMR transitions are induced by linearly polarized radio frequencies (rf) pulses, with the
magnetic field oscillating in the plane perpendicular to B0. It is conventional to represent
the oscillatory field as a sum of two circularly polarized components, each of amplitude
B1, counter-rotating in the xy-plane at angular velocity ω. One of these components will
rotate in the same sense as the nuclear spin precession:
B1(t) = B1[cos(ωt)i− sin(ωt)j] (4.15)
and it will be responsible for the resonance phenomenon when ω equals ω0. The counterro-
tating component can be ignored provided B1  B0, which is invariably the case in NMR
experiments.
The necessity of using circularly polarized rf comes from quantum mechanical selection
rules, dictating that NMR signals can only arise when the ∆m of the corresponding tran-
sition equals -1 [28].
4.1.4 Variable magnetic fields
Let us consider the effect on the bulk magnetization of a generic variable field B(t). Ac-
cording to classical mechanics:
dJ(t)
dt
= M(t)×B(t) (4.16)
where J is the bulk spin angular momentum, defined, analogously to Eqn. 4.11, as:
J =
∑
i
Ii. (4.17)
Substituting Eqn.s 4.11, 4.17 and 4.3 in Eqn.4.16, and multiplying each side by γ, we
obtain:
dM(t)
dt
= γM(t)×B(t) (4.18)
which is the equation of the motion of M in the laboratory reference frame.
In our case, B is the sum of the static field B0 and the rotating rf field B1 :
B(t) = B0 +B1(t) (4.19)
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so, it is convenient to introduce a new reference frame, (x′, y′, z′), with z′ ≡ z and the
x′y′-plane rotating around z at a velocity ω. The transformation rules can be succinctly
written in complex notation, as:
Mx′y′ = Mxye
iωt (4.20)
Mz′ = Mz (4.21)
where the magnetization vector is chosen as an example, and:
Mxy = Mx + iMy (4.22)
Mx′y′ = Mx′ + iMy′ . (4.23)
Rewriting Eqn. 4.15 in complex notation:
B1xy(t) = B1e
−iωt (4.24)
and applying the transformation of Eqn. 4.20, it is clear that in the rotating frame, B1
is a static field lying in the x′y′-plane (see Eqn. 4.15). In fact, the x′-direction is chosen
along B1. In the rotating frame, Eqn. 4.18 becomes (see [29]):
dM
dt
= γM ×Beff (4.25)
where Beff is called effective field :
Beff = B +
ω
γ
(4.26)
and:
ω = −ωk (4.27)
where k coincides with k′. Eqn. 4.25 shows that the ordinary equations of motion appli-
cable in the laboratory system are valid in the rotating frame as well, provided that Beff
is used instead of B. In other words, the magnetization will precess about Beff .
4.1.5 Effect of the rf pulse
Recalling Eqn. 4.19, Beff can be written as:
Beff = B0 +B1 +
ω
γ
= (B0 − ω
γ
)k +B1 (4.28)
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where Eqn.s 4.6 and 4.27 have been used. Under resonance conditions (ω = ω0), holds:
Beff = (
ω0
γ
− ω
γ
)k +B1 (4.29)
where Eqn. 4.14 has been used. Note that, the longitudinal component of the effective
fields gets deleted. According to Eqn. 4.25 and last findings, when a rf pulse of length τ
is applied to the sample, M precesses about B1 (i.e., x′ ) with the velocity:
ω1 = γB1. (4.30)
Therefore, at the end of the pulse, the magnetization will form the angle:
α = ω1τ (4.31)
with the z-axis (see Fig. 4.1b). α is called Flip Angle (FA) and it is one of the most im-
portant parameters characterizing an rf pulse in NMR. A 90◦-pulse flips the magnetization
down to the y′-axis and is called saturation pulse, since it equals the populations of the
spin states. In the laboratory frame, the M precession around B0 has to be added. The
resulting magnetization motion is a spiral trajectory like the one shown in Fig. 4.1a.
Figure 4.1. Evolution of the magnetization vector in the presence of an on-resonance rf
pulse. In the laboratory frame (a), the magnetization simultaneously precesses about M0 at
ω0 and about B1 at ω1. In the rotating frame (b), the effective longitudinal field is zero and
only the precession about B1 is apparent.
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4.1.6 After the pulse
In 1946 Felix Bloch formulated a set of equations describing the behavior of a nuclear spin
in a magnetic field, under the influence of rf pulses. He modified Eqn. 4.25 to account for
the observation that nuclear spins relax to equilibrium values, following the application of
rf pulses. Bloch assumed they relax, following first order kinetics, along the z-axis and
in the xy-plane at different rates, designated 1/T1 and 1/T2, respectively. The relaxation
processes regulated by the characteristic times T1 and T2 are called longitudinal (or spin-
lattice) and transverse (or spin-spin) relaxation, respectively (see section 4.1.8).
Adding relaxations, Eqn. 4.25 becomes:
dM
dt
= γM ×Beff − Mx
′i′ +My′j′
T2
− (Mz′ −M0)k
′
T1
(4.32)
where M0 is the thermal equilibrium value of Mz, that is, at equilibrium:
M = M0k
′. (4.33)
During the application of the rf pulse, the relaxation influence in the magnetization motion
can be neglected, since the length of the pulse is always much shorter than T1 and T2. After
the end of the pulse B1=0, so in the Larmor-rotating frame, also Beff is null (see Eqn.
4.29), and the Bloch equation simplifies as:
dMx′y′
dt
= −Mx′y′
T2
(4.34)
dMz′
dt
= −(Mz′ −M0)
T1
(4.35)
where Mx′y′ and Mz′ are the transverse and longitudinal magnetization components, re-
spectively. One can verify that the solutions to Eqn.s 4.34 and 4.35 are:
Mx′y′(t) = Mx′y′(0)e
−t/T2 (4.36)
Mz′(t) = Mz′(0)e
−t/T1 +M0(1− e−t/T1) (4.37)
where t = 0 means immediately after the end of the pulse. If the system was at thermal
equilibrium before the pulse, then:
Mx′y′(0) = M0 sinα (4.38)
Mz′(0) = M0 cosα (4.39)
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where α is the pulse flip angle.
The combined effect of free precession and relaxation can be seen by putting the magneti-
zation vector back to the laboratory frame. Specifically, applying the transformation rules
in Eqn.s 4.20 and 4.21 to Eqn.s 4.36 and 4.37, respectively, we obtain:
Mxy(t) = Mxy(0)e
−t/T2e−iω0t (4.40)
Mz(t) = Mz(0)e
−t/T1 +M0(1− e−t/T1) (4.41)
where Mxy(0) is the transverse magnetization observed in the laboratory frame, immedi-
ately after the rf pulse. Eqn.s 4.40 and 4.41 describe the magnetization precessing in the
xy-plane of the laboratory frame at the Larmor frequency, while it is relaxing along the
z-axis at a rate 1/T1 and relaxing in the xy-plane at a rate 1/T2.
4.1.7 Signal from precessing magnetization
According to Faraday induction law and the principle of reciprocity, the signal in a NMR
experiment is detected as the electromagnetic force (emf) induced by the precessing mag-
netization in a receiver coil (a conducting loop) [29]:
emf = −∂ΦM (t)
∂t
= − ∂
∂t
∫
sample
M(r, t) ·Brec(r)dr (4.42)
where ΦM is the time-varying magnetic flux through the coil and Brec is the magnetic
field produced at location r by a hypothetical unit current flowing in the coil. The coil
is placed around the sample with its symmetry axis perpendicular to the polarizing field,
so only the transverse magnetization can induce some signal. A common configuration is
to use the same rf coil to transmit B1 fields to the object and to receive signal from the
magnetization.
Let us analyze the signal generated by a 90◦-pulse on a system at thermal equilibrium. Ac-
cording to Eqn.s 4.38 and 4.40, the transverse magnetization component in the laboratory
frame at time t, following the pulse, is:
Mxy(t) = M0e
−t/T2e−iω0t (4.43)
where the pulse duration τ is assumed to be negligible with respect to the Larmor precession
time. This assumption allows to forget the phase shift accumulated during τ between
Mx′y′(0) and Mxy(0). If the receiver coil has a homogeneous reception field Brec over the
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sample, it can be shown that the signal takes the following expression:
S(t) = S(0)e−t/T2e−iω0t (4.44)
where S(0) is the signal amplitude immediately following the pulse, a number which de-
pends on the hardware configuration and which is proportional to M(0). The primary
NMR signal is measured in the time domain as an oscillating, decaying emf induced by the
magnetization in free precession. It is therefore known as the Free Induction Decay (FID).
An example of FID is represented in Fig. 4.2.
Figure 4.2. Typical example of FID signal. Signal and time are expressed in arbitrary units.
4.1.8 Relaxation mechanisms
As already discussed, the equilibrium net magnetization along B0 can be perturbed by an
rf pulse with a frequency exactly matched to the energy difference between the two spin
population states. Once the perturbing field is turned off, the nuclear spins start to relax,
due to different relaxation mechanisms, to claim back their equilibrium state.
Adopting a phenomenological approach, we observe that spins relax along the z-axis and
in the xy-plane at different rates, designated 1/T1 and 1/T2, respectively. However, the
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description of the mechanisms underlying spin-lattice and spin-spin relaxations needs a
microscopic approach.
Spin-lattice relaxation
The mechanism responsible for the returning of the longitudinal component of the mag-
netization to its equilibrium value is known as spin-lattice relaxation. The spin-lattice
relaxation time T1 manages the energy exchange between the spin system and the lattice.
In a non-equilibrium situation due to different populations in the two energy states, the
transition to the equilibrium state is accomplished by energy transfer from the spin system
to the lattice. Because the non-equilibrium state is a thermodynamic in stable state, T1 is
also a measure of the thermodynamic coupling. A spin in the high-energy state can make a
transition to the low-energy state either via spontaneous emission or stimulated emission.
However, since the probability of spontaneous emission depends on the third power of the
frequency, the probability for spontaneous emission is too low to be significant at radio
frequencies. As a result, all NMR transitions are stimulated.
In order to undergo a transition, the spin needs stimulation in form of a fluctuating mag-
netic field with components at the Larmor frequency in the xy-plane. Such a field is
produced by the random motions of the molecules in the surrounding medium. As the
molecules move around, they carry the nuclear magnetic moments with them generating
a magnetic noise at the site of any nucleus. The broad frequency range of this noise will
cover the Larmor frequency of the nuclei, stimulating a transition back to the lower energy
level, that is an energy exchange between the spin system and the lattice.
Several processes, commonly referred to as T1-processes, can generate magnetic noise,
namely magnetic dipole-dipole, electric quadrupole, chemical shift anisotropy, scalar cou-
pling and spin rotation interactions. All mechanisms contribute to the observable T1 ac-
cording to the following [30]:
1
T1
=
∑
m
1
T1,m
(4.45)
where T1,m is the time constant of mechanism m.
Spin-spin relaxation
The magnetization present in the transverse plane after an rf excitation decay toward zero
due to a process known as spin-spin relaxation. Immediately after a 90◦ rf pulse, the
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individual nuclear magnetic moments have the maximum phase coherence. This phase co-
herence would be maintained if all the protons experienced exactly the same local magnetic
field. However, this is not the case in real systems, where the local field experienced by
each proton is affected by its surroundings. Therefore, magnetic moments will gradually
lose their phase coherence (dephasing), leading to the disappearance of a detectable net
transverse magnetization.
The two main sources of dephasing are: extrinsic magnetic inhomogeneities (T2-relaxation
processes) and intrinsic magnetic inhomogeneities (T2-relaxation processes). Extrinsic in-
homogeneities arise from instrumental imperfection of the polarizing field, application of
magnetic field gradients (see section 4.2) and magnetic susceptibility differences within the
sample. At the interfaces (e.g., air/water interface) where there is a sudden change in
magnetic susceptibility (∆χ), protons experience a significant change in the local magnetic
field over a short distance [31].
The slight difference in B0 from point to point will result in a frequency distribution:
∆ω = γ∆B0 (4.46)
and hence in a dephasing.
Extrinsic magnetic inhomogeneities are time invariant and their dephasing effect can be
reversed by an additional 180◦ rf pulse (see section 4.3). On the other hand, intrinsic
magnetic inhomogeneities are due to the magnetic noise around the spins and cannot be
reversed by 180◦ pulses.
Extrinsic and intrinsic processes contribute to the transverse relaxation as follows:
1
T ∗2
=
1
T2
+
1
T ′2
(4.47)
where T ∗2 is the observed or effective spin-spin relaxation time (T ∗2 < T2).
4.1.9 From spectra to images
Effect of magnetic field gradients
In conventional NMR spectroscopy the spectrum of nuclear precession frequencies gives
information about the chemical environment of the spins and it is very important that the
polarizing field, B0, varies as little as possible across the sample.
In NMR the resonance frequency varies between 10 and 100 MHz, depending on the mag-
netic field applied. The associated wavelength is bigger than human body dimensions and
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Figure 4.3. T1 and T2 versus the molecular motion correlation time τc. For rotational
motion, τc is defined as the time the molecule takes to rotate pi/2 radians, while for transla-
tional motion τc is the average time between molecular collisions. Molecules in liquids have
shorter correlation time than molecules bound to a gel or solid matrix.
it would not be possible to have a resolution power in the range of mm. The idea of Lauter-
bur to overcome this problem became the key element of an NMR imaging experiment:
the presence of gradients varying linearly the field magnitude across the sample, in order
to encode the signal of the spins in space.
In two-dimensional (2D) Fourier Imaging, one of the most common imaging technique,
the spatially localized magnetic resonance information is obtained through the sequential
application of three perpendicular pulsed gradients. Each gradient has a different effect,
generally referred to as slice selection, phase encoding and frequency encoding.
Slice selection
Slice selection (or selective excitation) is performed by applying a magnetic field gradient
during the rf excitation. Often, the direction of the slice selective gradient is chosen along
z (the direction of the static magnetic field, B0) so, for the sake of simplicity, here we will
consider only this case, referring to the slice selection gradient as Gz, where:
Gz =
∂B0
∂z
(4.48)
Analogous definitions take Gx and Gy.
It is worth stressing that, in any case, only the magnitude of the static field is influenced
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by the gradients, whereas the direction of B0 remains constant all over the sample.
In presence of Gz the Larmor frequency becomes a function of z, i.e.,
ω = −γ(B0 +Gzz). (4.49)
By exciting the sample with an rf of ωrf, only the spins about
z = −ωrf + γB0
γGz
(4.50)
will be rotated into the xy-plane, contributing to the final signal, thus selecting a plane of
the sample perpendicular to B.
For a rectangular rf pulse of duration τ , there will be a spread of frequencies described by
the Fourier Transform (FT) of a rectangular window function, i.e., a sinc function centered
on ωrf, with a bandwidth proportional to 1/τ .
The approximate width of the slice selected will thus be:
∆z ∼ 1
γGzτ
. (4.51)
The duration of the rf pulse is the main parameter controlling the slice thickness. A slice
profile that is a sinc function however is not ideal, as it produces substantial excitation in
the lobes away from the selected slice. Improved slice profiles can be obtained by using
excitation pulses of different shapes, like sinc or Gaussian.
Frequency and phase encoding
Once the slice has been excited, the frequency and phase of the precessing macroscopic
magnetic moment can be made a function of position within the slice. In the simplest
case, if a magnetic field gradient in the x-direction, Gx, is switched on during the signal
acquisition, then the Larmor frequency becomes a function of x (frequency encoding):
ω(x) = −γ(B0 +Gxx) (4.52)
and the slice is cut into strips of constant Larmor frequency. Ignoring the T2 decay, an
area dxdy in the selected slice gives a contribute dS(t) to the total signal:
dS(t) = ρ(x, y)e−iγ(B0+Gxx)tdxdy (4.53)
where ρ is the proton density function and the time origin is set at the Gx activation (i.e.,
at the beginning of the signal acquisition).
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Demodulating the signal, to remove the carrier frequency γB0, and integrating over the
slice, we obtain the following expression for the total signal:
S(t) =
∫ ∫
ρ(x, y)dy︸ ︷︷ ︸
ρy−projection
e−iγGxxtdx (4.54)
where we recognize the ρ projection along the y-axis.
The ρ projection along y can be resolved applying, for a certain amount of time, a gradient
along y, immediately following selective excitation and just before signal acquisition. By
briefly turning on the Gy field gradient, the precessional phases of the rotating macro-
scopic magnetization can be manipulated as follows. Gy induces a variation of the Larmor
frequency along the y-direction, according to:
ω(y) = −γ(B0 +Gyy). (4.55)
If Gy is now turned off after a time τy,M returns to the constant frequency ω0, but having
accumulated a phase shift, φ, as a function of y (phase encoding), i.e.,
φ(y) = γGyyτy. (4.56)
If the frequency encoding gradient is now turned on and the signal acquired, then the FID
is a function of t and τy i.e.,
S(t, τy) =
∫ ∫
ρ(x, y)e−i(γGxxt+φ(y))dxdy
=
∫ ∫
ρ(x, y)e−i(γGxxt+Gyyτy)dxdy. (4.57)
Using Gx and Gy we have indexed each nutated macroscopic magnetic moment in the
selected slice, that is each (x, y) position, with an unique combination of Larmor frequency
and Larmor phase, (ω, φ).
k-space and pulse sequences
Eqn. 4.57 can be conveniently rewritten as:
S(kx, ky) =
∫ ∫
ρ(x, y)e−i(kxx+kyy)dxdy (4.58)
where:
kx = γGxt (4.59)
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ky = γGyτy (4.60)
The plane defined by the k = (kx, ky) points is called k-space, and it plays an important
role in the interpretation of MRI experiments.
In Eqn. 4.58 we can note that S(kx, ky) and ρ(x, y) are FT-pairs.
The proton density over the slice (i.e., the image, in absence of relaxations) can thus be
obtained by taking the inverse 2D FT of the demodulated FID over the k-space. ky is
varied by stepping through different values of Gy, whereas kx is sampled by holding on the
frequency encoding gradient while sampling the signal discretely.
The acquisition of each line of the k-space (i.e., {∀(kx, ky) : ky = const}) implies at least
an rf pulse (the excitation), a series of gradient pulses, and the signal acquisition.
The time course between two subsequent excitation rf pulses is called repetition time, and
referred to as TR. The complex sequence of time delays, gradient and rf pulses is known
as pulse sequence. The total acquisition time of a slice, Tacq is thus given by:
Tacq = NyTR (4.61)
where Ny is the number of ky steps.
From the properties of the FT, we know that the signal acquired at each k-space location
contains information about the whole image, but the type of information varies across
the k-space. Most of the contrast of the final image is encoded at the center of the k-
space (small kx and ky), while its peripheral part accounts mainly for the high frequency
contributes to the image, that is resolution of details and noise.
The trajectory of the vector k during the pulse sequence can be written as:
k(t) = γ
∫ t
0
G(t′)dt′ (4.62)
where the time origin is now at the beginning of the sequence and G(t) is the general
function describing orientation, shape and duration of the magnetic field gradients applied
during the MRI experiment.
The k(t) formalism is of great help in interpreting complex pulse sequences.
Steady state and T1-weighted images
In order to let the longitudinal magnetization recover the thermal equilibrium before the
acquisition of the next line (and therefore obtaining the maximum signal) TR should be at
least 5-7 times T1. This is actually impractical for in-vivo imaging, due to the resulting
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too long acquisition time (Eqn. 4.61). In fact, TR is always set
<∼ T1.
After a few pulses, the recovered value of Mz reaches a steady state, depending upon the
T1 of the sample, but always lower than M0.
The longitudinal magnetization after the n-th TR interval is given by:
M (n)z = M
(n−1)
z cosα+ (1− E)(M0 −M (n−1)z cosα)
= (1− E)M0 +KM (n−1)z (4.63)
where α is the FA of the excitation pulse (Eqn. 4.31), and we define:
E = e−TR/T1 (4.64)
K = E cosα. (4.65)
Writing Eqn. 4.63 as a sequence, we have:
M (n)z = (1− E)M0(1 +K +K2 + · · ·+Kn) +Kne−TR/T1M0
= (1− E)M0 1−K
(n+1)
1−K +K
nEM0 (4.66)
and, since K < 1, for n→∞, the steady state value is:
M (n→∞)z = M
steady
z =
(1− E)M0
(1−K) (4.67)
A short TR, together with reducing Tacq, can thus be used to induce a contrast between two
regions of the sample having the same proton density, but different (T1-weighted image).
Multi-slice 2D imaging
The coverage of a 3D volume is accomplished through the multi-slice approach, by applying
a sequence of rf pulses, exciting different slices, within a single TR. During each TR, one
k-space line is acquired for all the slices, thus keeping the same Tacq of the single-slice
acquisition. On the other hand, TR has to be set long enough to allow for the pulse
sequence of each slice being executed.
Because of imperfect rf profiles, the immediate neighborhood of an excited slice is also
partly excited (slice cross-talk effect). In multi-slice imaging, this region cannot be included
in the following slice since the spins do not have time to recover toward equilibrium. To
overcome the problem, it is common either to leave a gap between slices, or to excite the
odd numbered slices first and the even numbered ones afterwards (interleaved acquisition).
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3D volume imaging
As an alternative to the 2D multi-slice approach for imaging 3D volumes, the 2D coverage
of k-space described in section 4.1.9 can be generalized to 3D.
The excitation pulse is used to select a thick slab of the sample, then the 3D k-space
is discretely sampled in both directions, ky and kz, through phase encoding. The read
sampling along the x-direction is carried out, as in 2D, with measurements at finite time
steps ∆t during the continuous application of a gradient Gx. The associated step in the
kx direction is:
∆kx = γGx∆t. (4.68)
The (kx, ky) position of each acquisition line is determined by applying the orthogonal
gradients Gy and Gz, for the τy and τz time intervals, respectively. The corresponding
steps in k-space are:
∆ky = γ∆Gyτy (4.69)
∆kz = γ∆Gzτz (4.70)
where ∆Gy is the difference in Gy intensity between two consecutive read lines, and anal-
ogously for ∆Gz.
Under 3D imaging conditions, the signal from a single rf excitation of the whole sample
can be written as a 3D FT of the proton density:
S(k) =
∫
ρ(r)e−ik·rdr. (4.71)
3D vs 2D
3D imaging presents several advantages in comparison with multi-slice imaging:
1. The ability to change the number of the Nz phase encoding steps over the excited
slab of thickness TH, gives the control over the size of the partition thickness ∆z =
TH/Nz without any limitation on the rf amplitude or duration. In general, higher z
resolutions are obtainable.
2. The Signal-to-Noise Ratio (SNR) can be enhanced, thanks to the higher flexibility
in setting the pulse program parameters available in 3D imaging, but achieving this
may come at the expense of increased imaging time [31].
3. Consecutive slices may be adjacent without cross-talk effects.
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4. Shorter TR are usable if necessary, since only one k-space line has to be acquired
each repetition.
On the other hand, the total acquisition time for 3D imaging is given by:
Tacq = NyNzTR (4.72)
where Ny and Nz denote the number of phase encoding steps along y and z. As evident
from the Eqn.s 4.61 and 4.72 the 2D imaging lasts much shorter time with respect to
the 3D imaging. An immediate consequence is the capability of acquiring more 2D than
3D images within the same time, thus allowing a higher temporal resolution, in dynamic
studies. A more indirect effect is due to the capability (but also the necessity, see section
4.1.9) of setting longer TR, given a certain Tacq, in multi-slice imaging. A longer TR implies
a higher steady-state value of the longitudinal magnetization, thus giving a higher SNR.
4.2 Gradient Recalled Echo
In the imaging sequences described so far, we always assumed to acquire FID signals (see
section 4.1.7), however this is almost never done in practice. In fact, after excitation and
phase encoding, the echo of the original FID is recalled by means of the read gradient,
and measured (Gradient Recalled Echo, GRE). The reason for this is best explained by
inspecting the meaning of FID and echo acquisitions in the k-space formalism.
Let us watch at the FID at first, and let us consider Eqn. 4.59. Up to the acquisition start
Gx is turned off, so kx = 0, while ky is determined by the phase-encoding (Eqn. 4.60). In
other words, as the acquisition starts the k point is located somewhere on the ky axis.
When Gx is turned on, kx increases linearly in time, that is k travels along a line parallel
to the kx axis in the positive direction, stepping according to the sampling frequency (Eqn.
4.68).
The k trajectory is shown with blue arrows in Fig.4.4a, note that only the kx > 0 half of
the k-space is sampled.
In the echo scheme, a negative read gradient (Gx = −G− where G− > 0) is applied in
the time interval τ−, before starting the acquisition. As a consequence, k moves in the
negative kx direction up to kx = −γG−τ−, and spins along x dephase according to:
φG(x) = −γGxxτ− = +γG−xτ− (4.73)
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canceling the signal.
Gx is then switched to the positive value G+ and the acquisition started.
k reverts its motion, traveling in the positive kx direction, and the spins start re-phasing,
increasing the signal. The phase coherence is completely recovered (the center of the echo)
after the time τ+, when:
φechoG (x) = +γG−xτ−︸ ︷︷ ︸
Gx<0
−γG+xτ+︸ ︷︷ ︸
Gx>0
= 0 (4.74)
and k reaches the ky axis.
The last part of the echo scheme resembles the FID acquisition: the Gx gradient is held
on for another τ+, k moves in the kx > 0 half and the signal cancels away again.
The time interval between the rf excitation and the center of the echo is called echo time
and it is referred to as TE . In order to minimize TE (see below), the negative lobe of Gx is
usually applied contemporaneously to Gy, and the general condition for having a GRE is:∫
TE
Gx(t)dt = 0. (4.75)
The k trajectory for the full echo sampling is shown with red arrows in Fig.4.4b, while
the scheme of the sequence, with the basic elements discussed above, is shown in Fig. 4.5.
Standard conventions for the sequences representation have be adopted [28].
Figure 4.4. k trajectories across the k-space for the FID and echo sampling schemes. The
visited sampling points in the two cases are shown as colored points.
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Figure 4.5. Scheme of the basic elements of the GRE sequence. The dashed blue
areas of the read gradient represent the echo condition expressed Eqn. 4.74. TR
and TE are also reported.
4.2.1 Echoes and T2-weighted images
The full echo sampling scheme confers two advantages over the FID acquisition:
• The double of the sampling k-points are acquired, so there is a factor 2 of SNR gain.
• The signal is sampled in a raster of k points centered at the k-space origin, therefore
there is not dispersion spectrum and ρ(r) can be calculated directly by taking the
modulus of the resulting FT.
• The delay between excitation pulse and acquisition start can be used for applying
the phase gradients or other magnetization manipulations.
There is, however, a difficulty with the full echo sampling scheme where T2 relaxation
is significant. The acquisition of the maximum of the signal is delayed at the center of
the echo, when part of the transverse magnetization is already lost. The effect is even
enhanced by the inhomogeneities in the static field introduced by the gradients, reducing
the transverse relaxation time to T ∗2 (Eqn. 4.47).
In order to maximize the signal, the minimum echo time should be chosen. A longer TE
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can, however, be employed to get an image contrast between areas having different T2,
thus obtaining a T2-weighted image.
4.2.2 Spoiling residual magnetization
If TR is set very short (TR ∼ T ∗2 ), a fraction of the transverse magnetization of the preced-
ing repetition can still be present at the acquisition time, disturbing the signal.
The spoiling is the method by which residual transverse magnetization is destroyed de-
liberately prior to the excitation pulse of the subsequent repetition. Sequences may be rf
spoiled or gradient spoiled, or both.
rf spoiling involves applying a phase offset to each successive rf excitation pulse.
Think of it as the same flip angle but in a different direction, so that the residual mag-
netization in the xy-plane always points in a different direction, preventing any build up
towards a steady state.
Gradient spoiling occurs after each echo by using strong gradients in the slice-select direc-
tion after the frequency encoding. Spins in different locations, experiencing a variety of
magnetic field strengths, precess at differing frequencies, thus, dephasing.
Magnetic field gradients are not very efficient at spoiling the transverse steady state. To
be effective, the spins must be forced to precess far enough to become phased randomly
with respect to the rf excitation pulse.
4.2.3 GRE signal
The steady state image signal for a GRE sequence is given by:
I = A
(1− e(−TR/T1)) sinα
1− e−TR/T1e−TR/T ∗2 − cosα(e−TR/T1e−TR/T ∗2 ) e
−TE/T ∗2 (4.76)
where A is a constant which takes into account the proton density and the receiver gain as
well, α is the FA of the excitation pulse, whereas T1, T2 and TR have their usual meaning.
When TR  T ∗2 (or under conditions of perfect spoiling of the transverse magnetization)
e−TR/T ∗2 approach zero; if also TE  T ∗2 holds, then Eqn. 4.76 reduces to:
I = A
(1− e−TR/T1) sinα
1− cosαe−TR/T1 . (4.77)
Recalling now Eqn. 4.67, from their similarity, we can understand that Eqn. 4.77 describes
the steady state signal and that can be analogously derived.
The dependence upon TR and FA of the GRE signal, as expressed in Eqn. 4.77, is shown
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in Fig. 4.6. Note how the FA corresponding to the maximum signal, conventionally called
Ernst angle, increases with TR.
Figure 4.6. Simulated GRE signal intensity, as expressed in Eqn. 4.77, vs FA. A and T1
are set to 1 and 1000 ms, respectively, while TR = 5, 50, 80 ms.
4.3 Spin Echo
In spectroscopic NMR sequences, signal echoes are obtained through a 180◦ rf pulse fol-
lowing the excitation pulse.
Immediately after a 90◦x excitation pulse, in the rotating reference frame, the magnetization
lies on the y-axis.
Due to field inhomogeneities, spins start dephasing by precessing in opposite directions
and at different speed. If, after a time τ , a 180◦y pulse is applied, the spins are flipped
around y so that, conserving their angular velocity, they start re-phasing. After another
τ , the spins are back in phase to give a Spin Echo (SE), where TE = 2τ .
In SE imaging sequences rf and gradient pulses are arranged so to synchronize the gradient
and spin echoes. Thanks to the y-axis flipping caused by the 180 rf pulse, the dephasing
due to field gradients is recovered completely. In other words, the only source of signal re-
duction is the pure spin-spin T2 relaxation, resulting in a net signal gain over GRE (where
T ∗2 is acting).
The main limit of SE imaging is that TR can not be set as short as in GRE, due to the
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higher complexity of the sequence. However, by making TR long compared to TE , it is
possible to generate several spin echoes in one TR interval. This is successfully utilized in
Fast Spin Echo (FSE) sequences, where single 90◦y pulse is followed by several 180◦y pulses.
Each 180◦y pulse creates an echo, which is individually phase encoded, and several k-space
lines of the same slice can thus be acquired following a single excitation.
Within TR, the transverse magnetization is subject to T2 relaxation, so last echoes of each
repetition are strongly T2-weighted, and the resulting image is T2-weighted as well.
4.4 Echo Planar Imaging
Echo Planar Imaging (EPI) is capable of significantly shortening MR imaging times, allow-
ing acquisition of images in 20-100 ms. This time resolution virtually eliminates motion-
related artifacts, therefore, making possible imaging of rapidly changing physiologic pro-
cesses. Echo-planar images with resolution and contrast similar to those of conventional
MR images can be obtained by using multishot acquisitions in only a few seconds. To
obtain this time resolution, multiple lines of imaging data are acquired after a single RF
excitation. Like a conventional SE sequence, a SE-EPI sequence begins with 90◦ and 180◦
RF pulses. However, after the 180◦y RF pulse, the frequency-encoding gradient oscillates
rapidly from a positive to a negative amplitude, forming a train of gradient echoes (4.7).
Each echo is phase encoded differently by phase-encoding blips on the phase-encoding
Figure 4.7. EPI scheme. Within each TR period, multiple lines of imaging data are
collected. Gx = frequency-encoding gradient, Gy = phase-encoding gradient, Gz =
slice selection gradient.
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axis. Each oscillation of the frequency-encoding gradient corresponds to one line of imag-
ing data in k space, and each blip corresponds to a transition from one line to the next in
k-space. This technique is called blipped echo-planar imaging [32]. In the original echo-
planar imaging method, the phase-encoding gradient was kept on weakly but continuously
during the entire acquisition [33]. Today, echo-planar imaging has many variants. In one of
these variants, asymmetric echo-planar imaging, data are collected only during the positive
frequency-encoding gradient lobe. The negative frequency-encoding gradient lobe is used
to just traverse back to the other side of k space [34]. This type of data collection strategy
is also used in flow-compensated EPI.
4.4.1 Diffusion Weighted Echo Planar Imaging
One of the most used application of EPI imaging concern the diffusion of water molecules
in tissues. As we said in section 3.6, diffusion is the random thermal motion of molecules
through a tissue compartment. The signal intensity at MR imaging is dependent among
other factors on water motion, which intrinsically produces contrast. Diffusion of water
molecules through a magnetic field gradient causes intravoxel dephasing and loss of sig-
nal intensity. Water molecules diffuse approximately at a rate of only 1:10 mm/sec. In
diffusion-weighted echo-planar imaging, image acquisition is sensitized to the diffusion of
water molecules by inserting very strong motion-sensitizing gradient pulses into the echo-
planar imaging pulse sequence. Diffusion pulses cause the echo-planar imaging MR signal
to dephase or to diminish in proportion to the random velocities of the diffusing water
molecules, within the order of magnitude of the voxel size during an echo time (TE).
These velocities have been referred to as intravoxel incoherent motion [35]. To obtain
diffusion-weighted images, a pair of strong gradient pulses (Gd) are added to the pulse se-
quence, usually of the SE-EPI type (spin echo ultrafast echo planar imaging preparation)
that is T2 weighted, see Fig. 4.8. The Gd pulse is applied along the x, y, or z direction to
obtain images of diffusion in the x, y, or z directions respectively. These twoGd pulses are
identical in amplitude and width (δ), separated by a time ∆, and placed symmetrically
about the 180◦ pulse. The function of the Gd pulses is to dephase magnetization from
spins which have diffused to a new location in the period ∆.
These pulses have no effect on stationary spins. For example, a stationary spin exposed
to the first Gd pulse, applied along the Z axis, will acquire a phase in radians given by
φ = 2piγ
∫
zGzdt (4.78)
40
4 – MRI sequences
Figure 4.8. This timing diagram shows two repetitions of a diffusion weighted sequence
The spin will acquire an equal but opposite phase from the second pulse since the pulses
are on different sides of the 180 degree RF pulse. Thus, their effects cancel each other out.
Vice versa, the spins of the water molecules that move in the direction of the gradients,
during the interval between the two gradient applications, will not be rephased by the
second gradient: they dephase in relation to the hydrogen nuclei of the immobile water
molecules (Fig. 4.9).
(a) (b)
Figure 4.9. a) Effect of the gradient pulses applied along z in stationary spins, b) effect of
the gradient pulses applied along z in moving spins.
The relationship between the signal (S) obtained in the presence of a GD in the i
direction (Gi) and the diffusion coefficient in the same direction (Di) is given by the
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following equation where So is the signal at Gi = 0.
S
S0
= exp
[
−(Giγδ)2Di(∆− δ
3
]
= exp(−bD) (4.79)
where γ is the gyromagnetic ratio, δ is the duration of the gradient , ∆ the time between the
two pulses. b represents the degree of diffusion weighting of the sequence, expressed as the
b-factor
[
s
mm2
]
, which depends on the following characteristics of the diffusion gradients:
• gradient amplitude
• application time
• time between the two gradients
Diffusion magnitude, calculated from the 3 diffusion images thus obtained, renders the
image weighted in global diffusion (trace image). Two diffusion sequences with different
b-factors can be used to quantitatively measure the degree of molecular mobility, by cal-
culating the apparent diffusion coefficient (ADC). ADC is represented in the form of a
map, whose values no longer depend on T2. An ADC hyposignal thus corresponds to a
restriction in diffusion. In current practice, diffusion imaging for cancer detection consists
of an acquisition with a b-factor b = 0 smm2 (T2-weighted) and imaging with a b-factor
= 600 smm2(with diffusion weighting). The stronger the gradients, the longer they are
applied and the more spread out in time, the greater the b-factor.The advantage of strong
gradients is that they avoid the need to lengthen gradient time and spacing, which would
impose an even longer TE (without removing the T2 weighting part of the signal).Pure
diffusion contrast is obtained when using b-values above 1000 smm2 . However, image quality
can be limited by signal loss that occurs at such b-values and higher. Diffusion sequences
are actually T2 weighted sequences, sensitized to diffusion by gradients. The contrast of
the diffusion image will have both a diffusion and a T2 component, which must be taken
into consideration in the interpretation. Namely, a hypersignal in the diffusion image with
b = 600 smm2 can either correspond to a diffusion restriction or to a lesion that is already
in T2 hypersignal (T2-shine-through).
4.5 Fat-suppression
Fat-suppression is used in routine magnetic resonance imaging for many purposes: to sup-
press the signal from normal adipose tissue, to reduce chemical shift artifact, to improve
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visualization of uptake of contrast material and to characterize tissues. The optimal fat-
suppression technique depends on the amount of lipid that requires signal suppression.
Fat-suppression is a generic term that includes various techniques, each with specific ad-
vantages, disadvantages, and pitfalls. Lipid protons and hydrogen protons from water
behave differently during an MR imaging acquisition, and fat-suppression techniques are
based on these differences. Two major properties are involved: first, there is a small differ-
ence in resonance frequency, δf0 , between lipid and water protons, which is related to the
different electronic environments. This so-called chemical shift allows frequency-selective
fat-saturation. Second, the difference in T1 between adipose tissue and water can be used
to suppress the fat signal with inversion-recovery techniques. The chemical shift between
lipid and water also allows fat-suppression with opposed-phase imaging.
During a fat-saturation acquisition, a frequency-selective saturation radio-frequency pulse
with the same resonance frequency as that of lipids is applied to each slice-selection radio-
frequency pulse. A homogeneity spoiling gradient pulse is applied immediately after the
saturation pulse to dephase the lipid signal (Fig. 4.10).
The signal excited by the subsequent slice-selection pulse contains no contribution from
lipid [36].
Figure 4.10. Fat-saturation. Diagram shows a frequency-selective saturation
radio-frequency pulse applied to each slice-selection radio-frequency pulse. OL
= olefinic fatty acid [36].
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4.5.1 Advantages
Fat-saturation is lipid specific. Therefore, this method is reliable for contrast material-
enhanced T1-weighted imaging and tissue characterization particularly in areas with a
large amount of fat. Fat-saturation is also useful for avoiding chemical shift misregis-
tration artifacts. Because fat-suppression is achieved by preceding the normal acquisition
with a frequency-selective saturation pulse, fat-saturation can be used with any imaging se-
quence. Signal in non-adipose tissue is practically unaffected as long as the saturation pulse
frequency and bandwidth are properly selected; the signal-to-noise ratio in adipose tissue
is of course decreased. Fat-saturation thus allows good visualization of small anatomic
details [36].
4.5.2 Disadvantages
To achieve reliable fat-saturation, the frequency of the frequency-selective saturation pulse
must equal the resonance frequency of lipid. However, inhomogeneities of the static mag-
netic field will shift the resonance frequencies of both water and lipid. In these areas, the
saturation pulse frequency might not equal the lipid resonance frequency; this discrepancy
would result in poor fat-suppression. Even worse, the saturation pulse can saturate the wa-
ter signal instead of the lipid signal; the result would be a water-suppressed image. Static
field inhomogeneities inherent in magnet design are relatively small in modern magnets
and can be reduced by decreasing the field of view, centering over the region of interest,
and autoshimming. However, substantial inhomogeneities can be caused by local magnetic
susceptibility differences. Inhomogeneities are also likely to occur in areas of sharp varia-
tions in anatomic structures.
Inhomogeneities in the radio-frequency field can also reduce the efficacy of fat-saturation.
For complete saturation of the lipid signal, the saturation pulse must be exactly 90◦. Where
the radio-frequency field is inhomogeneous, the pulse will be greater or less than 90◦ and
will leave residual fat signal. The problem can be exacerbated by use of surface coils. Even
when surface coils are used for reception only, the presence of such coils can distort the
transmitter field sufficiently so that substantial fat signal is left.
Besides technical problems, there are two other reasons why fat-saturation can result in
incomplete fat-suppression. First, the fraction of adipose tissue that is water will not be
saturated. Second, a small fraction of fatty acids (5%) have the same resonance frequency
as water, and signal from these fatty acids will be unsuppressed; such fatty acids, which
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are free or bound to triglycerides, are called olefinic fatty acids or alkenes. Therefore,
detection of a small amount of fat can be impaired.
The chemical shift between lipid and water increases with the strength of the magnetic
field (at 1.0 T, δf0 ≈ 150Hz; at 1.5 T, δf0 ≈ 220Hz). Fat-suppression is therefore of lower
quality when low-field-strength magnets are used because δf0 is small. It is thus difficult
to achieve effective lipid saturation without also producing water saturation [36].
4.6 Other principal techniques
4.6.1 Inversion-Recovery imaging
In inversion-recovery imaging, suppression of the fat signal is based on differences in the
T1 of the tissues. The T1 of adipose tissue is shorter than the T1 of water. After a 180◦
inversion pulse, the longitudinal magnetization of adipose tissue will recover faster than
that of water. If a 90◦ pulse is applied at the null point of adipose tissue, adipose tissue
will produce no signal whereas water will still produce a signal (Fig. 4.11). Therefore, the
fat signal can be suppressed by using a short inversion time inversion-recovery sequence
(STIR). As long as the repetition time is much longer than the inversion time (TI), the
null point will be at a TI (TInull) equal to 0.69 times the T1. The T1 and hence the
optimal TInull for achieving suppression of adipose tissue signal depend on the magnetic
field strength. At 1.5 T, TInull occurs at approximately 130-170 msec.
STIR imaging is usually performed with a fast spin-echo readout sequence, which allows
shorter acquisition times than does a conventional spin-echo sequence [36].
4.6.2 Opposed-phase imaging
The opposed-phase technique is based on phase differences in images acquired at different
echo times.
Because lipid protons and water protons have different resonance frequencies, the phases
of these protons relative to each other change with time after the initial excitation (Fig.
4.12).
Immediately after excitation, the lipid signal and water signal are in phase (i.e., the phase
difference between them is zero). However, water protons precess fractionally faster than
lipid protons; therefore, after a few milliseconds, the phase difference between the two is
180◦ (i.e., the phase is opposed). After a few more milliseconds, the water spins complete a
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Figure 4.11. Inversion-recovery imaging. Diagram shows the behavior of adipose
tissue signal and water signal during an inversion-recovery sequence. Note that the
water signal has not fully recovered at the beginning of the imaging sequence. FSE =
fast spin-echo imaging, LM = longitudinal magnetization, SE = spin-echo imaging,
TI = inversion time [36].
360◦ rotation relative to the lipid spins and the spins are again in phase. The spins can thus
be sampled in an in-phase or opposed-phase condition by selecting the appropriate echo
time. In general, this technique is applicable only to gradient-echo sequences. The 180◦
refocusing pulse used in spin-echo sequences always brings the lipid signal and water signal
back into phase regardless of the echo time. During an MR imaging sequence, the signal
within a voxel is the vector sum of the lipid and water signals of the protons within that
voxel (Fig. 4.13). The lipid signal and water signal are additive in in-phase images, but
in opposed-phase images the signal is the difference between the lipid and water signals.
Therefore, opposed-phase imaging reduces the signal from fatty tissue. Opposed-phase
imaging is best suited to suppressing the signal from tissues that contain similar amounts
of lipid and water. In tissues that contain predominantly lipid or predominantly water,
the reduction in signal is small. For example, in adipose tissue, voxels contain mainly
adipocytes and the signal from water is much smaller than the signal from lipid. The
small amount of water produces only a small reduction in signal. Therefore, the adipose
tissue signal is fairly high (Fig. 4.14) and the opposed-phase image is poorly fat suppressed.
Conversely, voxels that contain tissue infiltrated by fat or only small areas of adipose tissue
have a low signal in opposed-phase images. In this situation, the lipid and water signals
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Figure 4.12. Opposed-phase and in-phase imaging. Diagram shows the behavior of lipid (L)
signal and water (W) signal relative to the echo time (TE) during a gradient-echo (GRE)
sequence (1.5 T). OL = olefinic fatty acid, t = time [36].
Figure 4.13. Opposed-phase imaging. Diagram shows the signal within a heterogeneous
voxel. The signal is the vector sum of the lipid (L) and water (W) signals. According to the
phase of these signals, they add or subtract and produce a higher or lower signal within the
voxel. OL = olefinic fatty acid [36].
partially cancel. The signal in opposed-phase imaging is lower than the signal produced
with fat-saturation: in opposed-phase imaging, the signal consists of the water signal minus
the lipid signal; with fat-saturation, the signal consists of the water signal alone (Fig. 4.15)
[36].
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Figure 4.14. Opposed-phase imaging versus fat-saturation. Diagram shows the
respective signals from tissue with a large amount of fat. L = lipid, OL = olefinic
fatty acid, W = water [36].
Figure 4.15. Opposed-phase imaging versus fat-saturation. Diagram shows the
respective signals from tissue with a small amount of fat. L = lipid, OL =
olefinic fatty acid, W = water [36].
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Part I
Registration, Lesion Detection and
Discrimination for Breast Dynamic
Contrast Enhanced Magnetic
Resonance Imaging
For breast cancer detection and diagnosis, the main advantages of DCE-MRI over tradi-
tional imaging modalities are the possibility to obtain and analyze both morphological and
functional features related to malignant growth, the high sensitivity in invasive breast car-
cinoma detection and the ability to provide high resolution three-dimensional (3D) images
[37, 38, 39]. This technique relies on signal enhancement after the intravenous injection of
a two-compartment gadolinium-based paramagnetic contrast agent: the intensity increases
with the concentration of the contrast agent as it perfuses the tumoral vasculature and
diffuses in the extravascular extracellular space. The time-intensity curve is therefore cor-
related with neoangiogenic-induced vascular changes and allows to provide information on
tumor biological aggressiveness, to monitor tumor response to therapy and to define the
state of angiogenesis [24].
DCE-MRI shows promise in detecting both invasive and ductal carcinoma in situ cancers,
gives information on the biological aggressiveness of tumors and may be utilized to evaluate
response to neoadjuvant chemotherapy [37, 38, 39, 40]. However, DCE-MRI data analysis
requires interpretation of hundreds of images and is therefore time-consuming [41].
The CAD system developed during this thesis aids in the visualization of kinetic informa-
tion by providing color mapping, facilitates analysis through graphical and quantitative
representations and provides an index of suspicion. In order to compute morphological fea-
tures and kinetic curves for use in predicting pathology probability (discrimination step),
a step of motion compensation between unenhanced and enhanced images (registration)
and a procedure of lesion identification (lesion detection) are included. The system here
proposed is fully automatic, therefore do not suffer from high inter- and intra-observer
variability typical of manual or semi-automatic systems [42, 43, 44]. As it is not operator
dependent, a fully automatic lesion segmentation process has the potential to reduce read-
ing time and provide more reproducible results. Unfortunately, few papers have addressed
automatic lesion detection and segmentation techniques for breast DCE-MRI [45, 46, 47].
Furthermore, these methods have been tested only on non fat-saturated (fat-sat) contrast-
enhanced images. Since enhancing lesions may become isointense to adjacent fatty tissue
after contrast material injection, fat-saturation has been introduced to enhance the contrast
between lesion and surrounding tissue and to overcome the limitations due to subtraction
artifacts [38]. Fat-sat sequences, however, introduce additional challenges for breast lesion
segmentation, especially due to the lower signal-to-noise-ratio (SNR) within the breasts.
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Chapter 5
Breast DCE-MRI
5.1 Dynamic curves
Using dynamic datasets (i.e. the time-signal intensity curves), two different criteria may be
used to describe lesion enhancement kinetics. First, behavior of signal intensity in the early
phase after the administration of contrast material is evaluated by means of the steepness
of the post-contrast signal intensity curve; several descriptors are in use for this criterion:
“curve slope”, “early-phase enhancement rate”, or “enhancement velocity”, which have been
given by the percentage of increase in signal intensity with respect to the signal intensity
before the administration of contrast material.
Second, the behavior of signal intensity in the intermediate and late post-contrast periods
may be traced to derive diagnostic information. This time course is visualized by placing
a region of interest (ROI) on the lesion to plot the time-signal intensity curve. Visual or
quantitative evaluation is focused on the shape of the time-signal intensity curve: whether
the signal intensity continues to increase after the initial upstroke, whether it is cut off and
reaches a plateau, or whether it washes out.
5.1.1 Kuhl’s study: a milestone in the dynamic curves analysis
The study of Kuhl et al. [48] was basic to assess the relevance of the signal intensity time
course for the differential diagnosis of enhancing lesions in dynamic magnetic resonance
(MR) imaging of the breast. The study was a prospective trial with a standardized pro-
tocol. The protocol was tailored to selectively determine the diagnostic utility of signal
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intensity time course analysis in dynamic breast MR imaging (i.e. to elucidate its spe-
cific contribution to the differential diagnosis of enhancing lesions in breast MR imaging).
Time-signal intensity curves of enhancing lesions were plotted and presented to two radiol-
ogists who were blinded to any clinical or mammographic information of the patients. The
radiologists were asked to rate the time courses as having a steady, plateau, or washout
shape (type I, II, or III, respectively). The classification of the lesions on the basis of
the time course analysis was then compared with both the breast MR imaging diagno-
sis without time course analysis (i.e., based on enhancement rates) and with the lesions’
definitive diagnoses. The definitive diagnosis was obtained histologically by means of ex-
cisional biopsy or by means of follow-up in the cases that, on the basis of history, clinical,
mammographic, ultrasonographic (US), and breast MR imaging findings, were rated to be
probably benign.
Two hundred sixty-six breast lesions were examined with a two-dimensional dynamic MR
imaging series and subtraction post-processing. The enhancement rate was quantified by
means of an ROI-based determination of lesion signal intensity before and after the in-
jection of gadopentetate dimeglumine. In particular, ROIs were placed selectively in the
areas of the most rapid and strongest enhancement. The relative enhancement (percentage
of signal intensity increase) was calculated according to the enhancement formula:
SIpost − SIpre
SIpre
× 100, (5.1)
where SIpre is the pre-contrast signal intensity and SIpost is the post-contrast signal in-
tensity. To assess the early-phase signal intensity increase, the enhancement for the first
post-contrast image was calculated. By plotting the lesion signal intensity over time, the
time-signal intensity curve was obtained to depict the lesions’ enhancement behavior in the
early, intermediate and late post-contrast periods. The three curve types (Fig. 5.1) differ
in their signal intensity time courses in the intermediate and late post-contrast periods.
Type I is straight or curved. In type Ia, the straight type, the signal intensity continues to
increase over the entire dynamic period; in type Ib, the curved type, the time-signal inten-
sity curve is flattened in the late post-contrast period because of saturation effects. Type
II is a plateau in which there is an initial upstroke, after which enhancement is abruptly
cut off, and the signal intensity plateaus in the intermediate and late post-contrast periods.
Type III is a washout in which there is an initial upstroke, after which enhancement is
abruptly cut off, and the signal intensity decreases (washes out) in the intermediate post-
contrast period (i.e., 2-3 minutes after injection of contrast material).
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Figure 5.1. Schematic drawing of the time-signal intensity curve types. Type I corresponds
to a straight (Ia) or curved (Ib) line; enhancement continues over the entire dynamic study.
Type II is a plateau curve with a sharp bend after the initial upstroke. Type III is a washout
time course. On the left of the curves conjunction point is the early post-contrast phase. On
the right is the intermediate and late post-contrast phase.
From literature, the lesions were classified according to the different time-signal intensity
curves. A type I time course was rated to be indicative of a benign lesion, type II was
rated as suggestive of malignancy, and type III was rated as indicative of a malignant
lesion. Lesions were classified according to their early-phase enhancement rates as benign
if the relative signal intensity increase was less than or equal to 60%, indeterminate if it
was more than 60% and less than or equal to 80%, and malignant if it was more than 80%.
To determine the diagnostic accuracies, lesion classifications on the basis of the enhance-
ment rates and curve types was compared with the lesions’ definitive diagnoses.
The results of Kuhl’s study showed that the early-phase enhancement rate is markedly
higher in malignant lesions than in benign (Fig. 5.2) and that the shape-types II and III
of the time-signal intensity curve are suggestive of breast cancer, while type I is suggestive
of benign lesion (Fig. 5.3). Therefore, Kuhl et al. demonstrated that the classification
scheme of three curve types (Fig. 5.1) provides a very valuable insight to identify suspi-
cious volumes.
However, the analysis of lesion enhancement kinetics should not be used as a stand-alone
diagnostic criterion but that it should be integrated into the process of lesion differential
diagnosis. In fact, the following principles must be taken into account when dealing with
time courses: the time-signal intensity curve analysis seems most useful in the differential
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Figure 5.2. Bar graph shows the mean early-phase enhancement rates in breast
cancers, benign solid tumors, and fibrocystic changes (N/PFC: non proliferative
and proliferative fibrocystic change) ± SD (error bars). Enhancement rates are
calculated for the 1st post-contrast minute [48].
Figure 5.3. Bar graph shows the distribution of time-signal intensity curve types in malig-
nant lesions, benign solid lesions, and fibrocystic changes (N/PFC).
diagnosis of focal lesions with rapid enhancement. In malignant lesions with slow enhance-
ment, the underlying poor angiogenic activity may also prevent a washout or plateau time
course. Particularly lobular or scirrhous ductal invasive cancers (and possibly also ductal
carcinoma in situ) with slow or gradual enhancement may exhibit type I time courses (in
these lesions morphology is almost always suggestive). Besides, a washout phenomenon is
a very specific, albeit not very sensitive, indicator of malignancy.
5.2 DCE-MRI indications
Current indications for breast MRI include, but are not limited to:
1. screening.
a. Screening of high-risk patients.
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Recent clinical trials have demonstrated that breast MRI can significantly im-
prove the detection of cancer that is otherwise clinically and mammographically
occult. Breast MRI may be indicated in the surveillance of women with more
than a 20% lifetime risk of breast cancer (for example, individuals with genetic
predisposition to breast cancer by either gene testing or family pedigree, or in-
dividuals with a history of mantle radiation for Hodgkin’s disease). Although
there is no direct evidence that screening with MRI will reduce mortality, it is
thought that early detection by using annual MRI as surveillance, in addition
to mammography, may be useful.
b. Screening of the contralateral breast in patients with a new breast malignancy.
MRI can detect occult malignancy in the contralateral breast in at least 3% to
5% of breast cancer patients.
c. Breast augmentation - postoperative reconstruction and free injections.
Breast MRI using contrast may be indicated in the evaluation of patients with
silicone or saline implants and/or free injections with silicone, paraffin, or poly-
acrylamide gel in whom mammography is difficult. The integrity of silicone
implants can be determined by non-contrast MRI.
2. Extent of disease.
a. Invasive carcinoma and ductal carcinoma in situ (DCIS).
Breast MRI may be useful to determine the extent of disease and the presence of
multifocality and multicentricity in patients with invasive carcinoma and ductal
carcinoma in situ (DCIS). MRI can detect occult disease up to 15% to 30%
of the time in the breast containing the index malignancy. MRI determines
the extent of disease more accurately than standard mammography and phys-
ical examination in many patients. It remains to be conclusively shown that
this alters recurrence rates relative to modern surgery, radiation, and systemic
therapy.
b. Invasion deep to fascia.
MRI evaluation of breast carcinoma prior to surgical treatment may be useful in
both mastectomy and breast conservation candidates to define the relationship
of the tumor to the fascia and its extension into pectoralis major, serratus
anterior, and/or intercostal muscles.
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c. Post-lumpectomy with positive margins.
Breast MRI may be used in the evaluation of residual disease in patients whose
pathology specimens demonstrate close or positive margins for residual disease.
d. Neoadjuvant chemotherapy.
Breast MRI may be useful before, during, and/or after chemotherapy to evaluate
treatment response and the extent of residual disease prior to surgical treatment.
If used in this manner, a pretreatment MRI is highly recommended. MRI-
compatible localization tissue markers placed prior to neoadjuvant chemother-
apy may be helpful to indicate the location of the tumor in the event of complete
response with no detectable residual tumor for resection.
3. Additional evaluation of clinical or imaging findings.
a. Recurrence of breast cancer.
Breast MRI may be useful in women with a prior history of breast cancer and
suspicion of recurrence when clinical, mammographic, and/or sonographic find-
ings are inconclusive.
b. Metastatic cancer when the primary is unknown and suspected to be of breast
origin.
MRI may be useful in patients presenting with metastatic disease and/or axil-
lary adenopathy and no mammographic or physical findings of primary breast
carcinoma. Breast MRI can sometimes locate the primary tumor and define the
disease extent to facilitate treatment planning.
c. Lesion characterization.
Breast MRI may be indicated when other imaging examinations, such as ul-
trasound and mammography, and physical examination are inconclusive for the
presence of breast cancer, and biopsy could not be performed (e.g., possible
distortion on only one mammographic view without a sonographic correlate).
d. Postoperative tissue reconstruction.
Breast MRI may be useful in the evaluation of suspected cancer recurrence in
patients with tissue transfer flaps (rectus, latissimus dorsi, and gluteal).
e. MRI-guided biopsy.
MRI is indicated for guidance of interventional procedures such as vacuum as-
sisted biopsy and preoperative wire localization for lesions that are occult on
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mammography or sonography and demonstrable only with MRI [49].
5.3 Technical aspects of breast DCE-MRI image acquisition
The conventional breast MRI investigation begins pre-contrast with either T2 or T1-weighted
images. The signal from the body coil can be used to evaluate the position and anatomy
of the breasts. Furthermore, both axillae, the supraclavicular fossae, the chest wall and
anterior mediastinum can be checked (e.g., for enlarged lymph nodes). However, this is
not the purpose of a breast MRI, and this evaluation may also be omitted as there is no
evidence of its diagnostic value. Afterwards the signal from the dedicated double breast
coil should be used. T2-w fast spin echo images can be performed as a start. In the T2-w
images water-containing lesions or edematous lesions have an intense signal, and in this
sequence small cysts and myxoid fibroadenomas are very well identified. In most cases
cancer does not yield a high signal on T2-w images; thus, these sequences can be useful
in the differentiation between benign and malignant lesions. However, as most of these
lesions can also be identified onT1-w images, there is no evidence as yet of added value of
T2-w sequences in breast MRI.
The most commonly used sequence in breast MRI is a T1-w, dynamic contrast-enhanced
acquisition. As already said, the sequence is called “dynamic” because it is first performed
before contrast administration and is repeated multiple times after contrast administra-
tion. A T1-w 3D or 2D (multi-slice) spoiled gradient echo pulse sequence is obtained before
contrast injection and then repeated as rapidly as possible for 5 to 7 min after a rapid in-
travenous bolus of a Gd-containing contrast agent. Three-dimensional imaging indicates
that phase encoding, frequency encoding, and section encoding are all achieved by applying
suitable gradients during image acquisition. For 2D imaging, section encoding is achieved
by means of selective excitation.
Compared with 2D imaging, 3D imaging has the inherent advantage of stronger T1 con-
trast: 3D imaging uses a shorter repetition time than does 2D multisection imaging and
has a higher inherent signal-to-noise ratio, which therefore allows thinner sections (or par-
titions) to be acquired [38]. In turn, a 2D sequence suffers less from motion and pulsation
artifacts. Both sequences can be performed with and without fat-suppression. The choice
of the image orientation is important. For bilateral dynamic breast MRI, axial or coronal
orientations are most frequently used. Coronal imaging has advantage in that it can reduce
heart pulsation artifacts, but it is more susceptible to respiratory motion and also to flow
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artifacts because vessels tend to travel perpendicular to the slice-encoding direction. Al-
though bilateral sagittal imaging is possible today, it requires about double the number of
slices required for the other orientations. As this hampers the spatio-temporal resolution,
such an orientation is currently not feasible.
Temporal resolution. Peak enhancement in the case of breast cancer occurs within the
first 2 mins after the injection of contrast medium. Therefore, relatively short data acqui-
sition times, in the order of 60-120 s per volume acquisition, are necessary. This allows
sampling of the time course of signal enhancement after contrast injection, which is useful
because the highly vascularized tumor of the breast shows a faster contrast uptake than
the surrounding tissue. More importantly, it enables a detailed analysis of morphological
details, because only in the very early post-contrast phase, the contrast between the cancer
and the adjacent fibroglandular tissue is optimal. Tumors may lose signal (a phenomenon
referred to as “wash-out”) as early as 2-3 mins after contrast material injection, whereas the
adjacent fibroglandular tissue can still exhibit substantial enhancement, resulting in little
contrast between the cancer and the fibroglandular tissue. Long acquisition times will be
associated with the risk of not resolving fine details of margins and internal architecture;
this could have key importance for the differential diagnosis, and may even run the risk of
missing cancers altogether because they are masked by adjacent breast tissue.
A dynamic sequence demands at least three time points to be measured, that is, one be-
fore the administration of contrast medium, one approximately 2 mins later to capture the
peak and one in the late phase to evaluate whether a lesion continues to enhance, shows a
plateau or shows early wash-out of the contrast agent (decrease of signal intensity). It is
thus recommended to perform at least two measurements after the contrast medium has
been given, but the optimal number of repetitions is unknown. However, the temporal
resolution should not compromise the spatial resolution.
Spatial resolution. Detailed high spatial resolution is the other prerequisite for diagnosing
breast cancer with the aid of MR imaging. This is in close agreement with mammography
or breast ultrasonography (US), where for the past several years attempts have been made
to further improve the visualization of morphological details. The final spatial resolution of
the images depends on different factors, especially the size of the imaging volume, defined
by the field of view (FOV), the slice thickness and the acquisition matrix. Breast MRI
should be capable of detecting all lesions larger than or equal to 5 mm. Therefore, the
voxel size should be under 2.5 mm in any direction. Preferably, the in-plane resolution
should be substantially higher as morphologic features needed for lesion characterization,
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such as margin appearance, can only be evaluated when the resolution is sufficiently high.
Therefore, the in-plane resolution should be at least 1 mm−1, in other words: pixel size
(FOV/matrix) should not be greater than 1×1 mm, which requires a matrix of at least
300×300 in a 300-mm FOV.
In breast MR, however, acquisition speed and spatial resolution are diverging demands.
Any increase in spatial resolution (e.g., an increase in the size of the acquisition matrix) is
associated with an increase in acquisition time [38, 50].
5.4 MRI protocols
The dataset has been divided in two groups. Group A included all studies acquired on a 1.5
Tesla (T) scanner (Signa Excite HDx, General Electric Healthcare, Milwakee, WI) using
a eight-channel breast radiofrequency coil and a fat-sat three-dimensional (3D) axial fast
spoiled gradient-echo sequence (VIBRANT®, General Electric) with the following tech-
nical parameters: repetition time/echo time (TR/TE)=4.5/2.2 ms, flip angle 15°, recon-
structed matrix 512x512, field of view 32 cm, slice thickness 2.6 mm,pixel size 0.39 mm2.
A total of seven scans were acquired for each study: one baseline, 5 contrast-enhanced
frames with 50-s time resolution, and one delayed frame acquired 7 minutes after contrast
injection. Gadopentetate dimeglumine (Gd-DPTA, Magnevist, Bayer-Schering, Berlin,
Germany) was administered at a dose of 0.1 mmol/kg at 2 mL/s, followed by 20 mL of
saline solution at the same rate.
Group B comprised studies performed on a different 1.5T scanner (Sonata Maestro Class,
Siemens, Erlangen, Germany), using a dynamic 3D axial spoiled fast low angle shot se-
quence using a four-element two-channel coil, with the following technical parameters:
TR/TE=11/4.9 ms, flip angle 25°, matrix 512x512, field of view 384 mm, slice thickness
1.3 mm, pixel size 0.56 mm2. Gd-BOPTA (MultiHance, Bracco, Milan, Italy) was used as
contrast agent, administering 0.1 mmol/kg at 2 mL/s, followed by 20 mL of saline solution
at the same rate. One baseline scan was acquired before contrast injection, followed by
5 contrast enhanced frames taken 118 s apart. Fat-sat sequences were not performed in
group B patients. A training and a testing set were developed by randomly selecting studies
from the 2 groups. The training set was used to optimize the parameters of the algorithms,
whereas system performances were evaluated on the testing set. The characteristics of the
training set are detailed in Figure 5.4. Lesion greatest diameter was measured manually
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Figure 5.4. Flow diagram showing main demographic, clinical and technical information
of the study database. °Fat-sat=fat-saturation scans. °°Non-fat-sat = non-fat-saturated
images. ∗DCIS = Ductal Carcinoma In Situ.
by an experienced radiologist with an electronic caliper on the axial plane at its maximum
extension. Median diameter was 16 mm (range, 12-37 mm) for benign lesions and 19 mm
(range 5-90 mm) for malignant lesions; 6 of the 36 malignant lesions were sized 10 mm
or less. The reference standard was surgery and histological evaluation or follow-up in
some benign lesions. Enhanced areas smaller than 5 mm in diameter, the so-called foci
according to the definition of the American College of Radiology (ACR) Breast Imaging
Reporting and Data System (BI-RADS) for breast MRI, were not evaluated. In the ma-
jority of cases, these foci are due to a focal proliferation of glandular tissue, known as focal
adenosis [38]. The studies of both datasets were acquired with the patient in the prone
position, as illustrated in Fig. 5.5.
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Figure 5.5. Patient prone position during DCE-MR exam.
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Chapter 6
Breast lesion detection methods
The lesion detection pipeline consists of four main processing steps: breast segmentation,
image registration, lesion detection and false positive (FP) reduction, none of which re-
quires user interaction (see Fig. 6.1). Breast segmentation automatically identifies the
breast and axillary regions to reduce the computational burden and prevent FPs due to
enhancing structures (such as the heart and extra-breast vessels). The contrast-enhanced
images are then registered to the unenhanced image to correct for possible misalignments
in the dynamic sequence due to patient’s movement. The lesion detection step consists in
the extraction of suspicious contrast enhanced areas and the FP reduction step identifies
and discards regions incorrectly extracted.
6.1 Breasts segmentation
This process includes the identification of the approximate size and location of each breast,
and the breast segmentation itself. A rough estimate of breast location was obtained by
identifying the most anterior point reached by the breasts, which is defined as the maximum
point, and the minimum point which is the deepest point within the concavity between
the breasts, as shown in Figure 6.2. These measures were obtained following a rough
segmentation of the patient’s body. To separate the skin and internal structures from
external air, Otsu’s thresholding algorithm [51] was applied to the unenhanced images.
This algorithm also allows for removing air from lungs and other low intensity areas.
Because of the high intensity noise, the Otsu thresholding algorithm may generate areas
in the external air. To remove these areas, the largest connected region, i.e. the breasts,
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Figure 6.1. Main steps for breast segmentation and lesion detection for a non-fat-sat study.
The unenhanced frame is shown in (a); the mask resulting from breast segmentation is
shown in (b). In (c) the maximum intensity projection (MIP) along the z axis of the second
enhanced subtracted frame is shown before registration: subtraction artifacts due to patient
movement are visible as spurious enhancing voxels (arrows). In (d) the same subtracted
MIP after registration is shown: motion artifacts have been removed (arrows). In (e) the
results of automatic lesion detection are shown, while in (f) the segmentation results after
false positive reduction by means of morphological and kinetic criteria are illustrated.
was selected by the algorithm and morphological operations were then applied to fill holes
(six dilations and six erosions, both using a 5×5×5 kernel). The algorithm then searches
for the maximum point, as previously defined, on the Otsu mask (Fig. 6.2(c)), and for the
central line C, defined as the line running along the concavity between the breasts. Once
the breasts size and location have been identified, breast segmentation itself can be done.
This part of the algorithm is performed differently depending on whether fat-saturation
was used, as determined automatically by the DICOM header.
6.1.1 Breast segmentation for non-fat-saturated images
The boundary between air and the breasts is easily detected by scanning each slice of the
Otsu mask (Fig. 6.2(c)) along vertical lines starting from the anterior part of the image.
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(a) (b)
(c) (d)
Figure 6.2. a) pre-contrast image; b) result of Otsu’s thresholding. The largest con-
nected region comprises also the skin profile; c) result of morphological operations (6
dilations and 6 erosions, both with kernel 5×5×5). For each slice, every vertical line
is scanned until the patient body is reached. The position of the central line and the
breast’s maximum point (shown by arrows) are identified; d) the mask obtained at step
(c) is also used to remove external air from the pre-contrast image in order to suppress
noise and artifacts in the external air.
Then, to locate the breast-chest boundary we exploit the anatomical features of the pec-
toral muscle, which is located between the breasts and the chest wall. The average muscle
intensity is lower than the fat within the breasts, but higher than the air in the lungs;
therefore, it is characterized by a positive gradient along the border within the breasts
fat tissue (denoted in the following as “upper border”), and a negative gradient at the
chest wall border (denoted “lower border”in the following). As the pectoral muscle can be
anatomically modeled as a smooth and thin slab of tissue, the approximate location of the
upper border in the i-th slice can be estimated by placing a diagonal line passing from the
i -th point of the central line, Ci, with a slope of 0.15 towards the right and -0.15 towards
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the left [52]. Such diagonal lines will be used to bound the position of the actual upper
border as described in the following (see Fig. 6.3). The upper and lower border is then
located based on the image gradients.
Figure 6.3. Determination of the breast-muscle interface. (a) Identification of the initial
seed points below the central line. (b) an upper bound is identified based on the diagonal
lines passing by the central point with a ±0.15 slope âĂŞ no lower bound is imposed on the
upper or lower border (c) the final upper border identified by the algorithm.
The algorithm starts by locating for each slice i a couple of points P u(x, yu) and
P l(x, yl) for each x in a limited interval of the x-coordinate of the i -th central line point
Ci(xi, yi). The set of P u and P l, identifying respectively the upper and lower border in
the region around Ci, are located according to the flow-chart shown in Fig. 6.4 (Output
1). However, in some cases errors could arise, for instance due to inhomogeneities in the
magnetic field. As P u and P l are used as seeds in the second part of the algorithm, it
is of paramount importance that they are correctly located to avoid propagating errors.
Step 2 in the flow-chart identifies erroneous voxels, based on the hypothesis that the upper
boundary is very smooth and hence the distance ∆yu should be very small, whereas Step
3 searches for a new suitable couple of points (see flow-chart in Fig. 6.4). The whole
upper and lower border profiles are then completed for all x-coordinates according to the
procedure reported in the dashed-box of the flow-chart in Fig. 6.4. In this part of the
algorithm the upper bound is also determined based on the position of the diagonal line,
i.e. yu(xj) < d(xj)+25 mm; this prevents the contour from being attracted to the gradient
between the gland and fat, in cases where the gland is very close to the pectoral muscle.
The whole procedure is repeated for all the slices of the images, with an additional control
for the position of the boundary in the corresponding xj in the previous slice: the distance
between yu(xj)sliceN and yu(xj)sliceN−1 should be less than 2.25. In order to obtain a
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closed contour even in regions where the pectoral muscle is not present, i.e. arms, if the
algorithm does not find a gradient magnitude greater than Tg, P u(yu(xj)) and P l(yl(xj))
are set as P u(yu(xj − 1)) and P l(yl(xj − 1)).
As both the position of the breast-air and the upper border of the pectoral muscle are
determined as a function of the x coordinate, the final segmentation can be obtained by
including all voxels between the two contours. The obtained mask is then refined with a
morphological closing, with kernel 2.5x2.5x2.5 mm.
This algorithm was tested on DCE-MRI cases from two different centers, with different
acquisition modalities, and evaluated by quantitative comparison with a manual segmen-
tation, performed by two operators. Overlap, recall, that is a statistical measure of under-
estimation of the segmented volume, precision, that is an index of overestimation of the
segmented volume, and mean surface distance between the segmentation and reference con-
tours were computed. Overall results of this segmentation method were 0.79 ± 0.09 (mean
Âś SD) for overlap, 0.95± 0.02 for recall, 0.82± 0.1 for precision, and 6.3± 3.93 voxels for
mean surface distance. The 95% of recall is very satisfactory, indicating that most of the
manually segmented regions are included in the segmentation, which is the most important
issue as undersegmentation may exclude lesions during the lesion detection step.
6.1.2 Breast segmentation for fat-saturated images
If fat-sat is used, intensity alone is not sufficient to obtain a reliable segmentation. In
this case, an a priori knowledge of the main anatomical structures in the field of view
was exploited, using an atlas-based segmentation scheme. A simplified atlas was used in
which the breasts, heart, chest wall and lungs have been previously manually segmented
and color-coded. Because breast size and shape may vary considerably across subjects,
three different atlases were generated for large, medium and small breasts 6.7. The patient
body was identified by the above mentioned Otsu’s thresholding method, the image was
down-sampled to a predefined resolution to reduce the computational burden, and then
registered to the appropriate breast atlas, by a rigid and an elastic registration algorithm.
Details of the registration algorithm used will be explained in Sec. 6.2. Two examples of
breasts segmentation results are shown in Fig 6.8. The two methodologies yield slightly
different results in the axillary area, but this is not compromising for the lesion detection.
Axillae, supraclavicular fossae, chest wall, and anterior mediastinum can be assessed by
breast MRI (e.g. to search for enlarged lymph nodes) but their evaluation could be omitted
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Figure 6.4. Flow-chart of the procedure to find the upper and lower pectoral muscle border
in the case of a single slice. xi, yi are the coordinates of the i-th point of the central line
Ci(xi, yi). n=5 pixels. Ig is the pixel gradient magnitude and Tg is the pixel gradient
maximum threshold (Tg = 10). d1 = 40mm, d2 = 20mm,d3 = 3mm, d4 = 2.25mm. u and l
apexes indicate respectively upper and lower border. The dashed-box encloses the procedure
needed to complete the upper and lower borders for pixels out of the central line interval.
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Figure 6.5. Results for two slices from one patient. Note the drop in signal intensity
away from the breasts coil. a) Automatic segmentation superimposed to the unenhanced
image. b) Automatic segmentation superimposed to the manual segmentation. c) Automatic
segmentation superimposed to the thresholding-based automatic segmentation method.
Figure 6.6. Segmentation results in the case of a tumor very close to the
pectoral muscle interface.
as there is no evidence of its diagnostic value [50].
6.2 Registration
The first step performed by a CAD system is the registration between images coming
from different datasets or acquired in different moments. During the DCE-MRI exam,
for example, six 3D images are acquired in around ten minutes. During this period the
patient undergoes involuntary (breathing, heart beating) and voluntary movements. In the
developed CAD system the registration between DCE-MRI volumes of the same patient is
performed.
The registration method, illustrated in Fig. 6.9, is based on the method proposed by
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(a) (b) (c)
Figure 6.7. Breast atlases corresponding to different breasts’ size. a) Model for pa-
tients with “large”breasts (estimated breast size > 10 cm ); b) model for patients with
“medium”breasts (estimated breast size < 10 cm and > 7 cm) and c) model for patients
with “small”breasts (estimated breast size < 7 cm). The represented anatomical regions are,
from brightest to darkest area: thoracic wall, breasts, hearth and chest wall.
Figure 6.8. Example of breast segmentation for studies acquired with fat-saturation
(different slices of the same patient are shown). The breast masks extends further than
in non-fat-suppressed sequences, as defined by the breast atlas. The breast model was not
deformed in the bottom part of the image, as only a smaller ROI is taken into account
by breast segmentation.
Rueckert [54], and was implemented using the insight toolkit (itk) [55] libraries based
on C++ language. To reduce the computational burden, the registration was performed
at a minimal predefined resolution in each axis direction. Therefore, if the frames of
the dynamic series presented a lower resolution in any of the directions, the images were
down-sampled to the predefined minimal resolution. Otherwise, registration was performed
at original resolution. In addition, the registration was performed within a rectangular
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Figure 6.9. (a) Scheme of the registration method. (b) Basic components of the registration
framework used for the rigid and non-rigid registration steps.
region of interest, containing the relevant part of the scans for the diagnosis (i.e. breasts
and axillae), which was automatically determined based on the maximum and minimum
points of the breast (as defined in section 6.1). The registration itself consists of two main
steps. First, the global misalignment was compensated by using a translation and a rigid-
body transformation. Subsequently, local motion was corrected by a free-form deformation
model based on B-splines [54]. The second step is necessary being the breast a deformable
tissue. In fact, even if the patients lays prone and the breasts are placed into the coil, a
small movement of the patient’s body can produce an elastic deformation on the breasts.
Image registration, rigid or free-form, can be considered as trying to maximize the amount
of shared information between two images, while reducing the amount of information in
the combined image, which suggests the use of a measure of information as a registration
metric [58]. Many metric have been presented in literature (i.e. correlation coefficient, sum
of the absolute difference), however this method may not take into account the difference
due to the amount of contrast agent during the dynamic acquisition, when the intensity
value of the pixel might change from one image to the other. The mutual information
metric, vice versa, is a measure of statistical dependency between two datasets, and is
given by
MI(X,Y ) = H(Y )−H(Y | X) = H(X)−H(Y )−H(X,Y ), (6.1)
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where X and Y are two random variables, H(X) = −Ex(log(P (X))) represents entropy of
a random variable and P (X) is the probability distribution of X. The method is based of
the maximization of the MI, in particular by the method specified by Mattes et al [56].
Finding the maximum of similarity measure is a multidimensional optimization problem,
that requires an iterative approach, in which an initial estimate of the transformation is
gradually refined by trial and error. In each iteration the current estimate of the transfor-
mation is used to calculate a similarity measure. The optimization algorithm then makes
another (hopefully better) estimate of the transformation, evaluates the similarity mea-
sure again, and continues until the algorithm converges, at which point no transformation
can be found that results in a better value of the similarity measure, to within a preset
tolerance. One of the difficulties with optimization algorithms is that they can converge
to an incorrect solution called a “local optimum”. In this CAD system, different optimizer
have been tested, but the most suitable were found to be the gradient descent optimizer
for the rigid registrations, and of the LBFGSB (Limited memory - Broyden, Fletcher,
Goldfarb, and Shannon - for Bound constrained optimization) optimizer for the nonrigid
sub-step [57]. If the contrast-enhanced frames were down-sampled before the registra-
tion, the respective deformation fields were up-sampled to the original resolution. Finally,
the original contrast-enhanced frames were warped to obtain the transformed (aligned)
contrast-enhanced frames by applying the respective deformation field. In the warping,
B-spline interpolation was used to minimize the introduction of sampling artifacts. The
registration method was tested on 24 patients from the group B (non fat-sat images).
Sixteen of 24 patients were randomly selected while the remaining 8 were added as they
presented relevant artifacts due to patient movement. The registration method was applied
to the enhanced sequences with reference to the unenhanced one. Registered (REG) and
non-registered (N-REG) axial images and maximum intensity projections (MIPs) of the
first enhanced subtracted frame were randomized and blindly evaluated by two radiolo-
gists separately by scrolling the axial images and rotating the MIPs, with free windowing.
Image quality was assessed for both axial images and MIPs. Readers were asked to de-
fine equivalence or superiority of one of the two datasets of each patient, simultaneously
presented. Finally, the CAD system performed the lesion detection step 6.3 identifying
suspicious enhancements (prompts) for REG and N-REG images. A radiologists excluded
prompts related to real findings; the remaining false prompts and their volume were ob-
tained for both REG and N-REG images. Image quality of REG-MIPs was found to be
significantly superior than that of N-REG-MIPs for both readers (p-value<0.001) with a
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quite good inter-rater agreement (k=0.5). Image quality of REG-axial images was found
to be slightly better than that of N-REG axial images by both readers without significant
difference. The mean number of false prompts per patient was 29.4±17.7 on N-REG and
25.0±16.5 for REG (p-value=0.041). Excluding one patient with wrong segmentation of
the heart, the mean volume of false prompts was 13,000±11,641 mm3 for N-REG and only
4,345±4,274 mm3 for REG (p-value<0.001). Two examples of how registration was able
to compensate for motion artifacts is shown in Fig. 6.10 and Fig. 6.11.
Figure 6.10. Comparison between subtracted images with and without registration. A
slice from a non-fat-sat examination is shown. (a) Subtraction artifacts due to patient
movement are visible along the breast profile (plain arrow), in the breast parenchyma
(dot arrow), at lesion and vessel borders, as well as at the borders of fat lobules. These
artifacts may introduce spurious enhancing voxels, thus increasing the number of false
positive findings at segmentation. (b) Subtraction artifacts are dramatically reduced
when elastic registration is used.
6.3 Lesion detection
Contrast enhancement of breast lesions shows large physiologic variations, mostly depend-
ing on differences in vascular permeability [59, 60] and other technical and physiological
parameters, including type and dose of contrast material [61, 62]. Differences may depend
on lesion histology, on the timing of imaging or on inhomogeneities within the lesions, such
as those observed in necrotic areas or in fibrosis. To take into account for the nonuniform
uptake of contrast, while reducing at the same time the computational burden associated
with the processing of all the contrast-enhanced registered frames, we used the subtracted
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Figure 6.11. Comparison of non-registered (a) and registered (b) MIPs. The image qual-
ity is significantly superior in registered images (in N-REG images the motion artifacts
introduce spurious enhancing voxels).
mean intensity projection image over time (mIPT). Being the dynamic sequence a 4D im-
age (x×y×z×t), where t is time, the mIPT is the 3D image (x×y×z) formed by averaging
each voxel along the t axis. Subtraction of the unenhanced frame was performed to neglect
the contribution of regions which do not show contrast enhancement. Different scanners,
coils, acquisition modalities, types and amounts of contrast agent injected, patients’s phys-
iology, and other external factors, result in significant variations of image intensities among
images acquired in different hospitals, in different patients, or even among different exam-
inations from the same patient [61, 62].
To compensate for these effects, the subtracted mIPT was normalized by contrast enhance-
ment of the mammary vessels. Because the mammary vessels show maximum contrast
enhancement in the early frames of the dynamic sequence, they were automatically seg-
mented on the first subtracted contrast-enhanced frame. A suitable ROI was automatically
selected based on the position of the central line by placing a rectangle of a fixed size (50
mm×100 mm) in each slice, with the exception of the upper 30% and lower 10% of the 3D
image slices that were not considered because the mammary vessels are not usually visible.
The mammary vessels were then identified by applying to the ROI the multiscale 3D Sato’s
vessel enhancement filter, which is based on the eigenvalues of the Hessian matrix [63, 64].
The Sato’s vessel enhancement filter considers the mutual magnitude of the eigenvalues as
indicative of the shape of the underlying object: isotropic structures are associated with
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eigenvalues which have a similar nonzero magnitude, while vessels present one negligible
and two similar nonzero eigenvalues. Let the eigenvalues of the Hessian matrix be λ1, λ2,
λ3 (with λ1 > λ2 > λ3). On a given scale, vesselness is thus defined as:
Vσ(λ1, λc) =

e
− λ
2
1
2(α1λc)
2 λ1 ≤ 0, λc /= 0
e
− λ
2
1
2(α2λc)
2 λ1 > 0, λc /= 0
0 λc = 0
(6.2)
where λc min (λ2, λ3), α1 and α2 were set to 0.5. The s footer in Vs indicates that the
vesselness is computed on a smoothed version of the image and is therefore representative of
the variations of image intensity on the s spatial scale. As vessels in the breasts could have
different diameters, the vesselness is evaluated on a range of spatial scales, and the highest
response is selected for each voxel. Specifically, the vesselness response is computed at 6
exponentially distributed scales between the maximum and minimum scales σmin = 0.5 and
smax = 1.0. The most vessel-like voxels are then selected by applying a threshold equal to
half the maximum vesselness value observed in the region of interest identified as described
above; in Fig. 6.12 the 3D view of an example of segmented mammary vessels is shown. The
Figure 6.12. a) Subtracted first post-contrast frame with the region where the mammary
vessels are located in yellow. b) Zoom of the region highlighted in a). c) 3D view of
segmented mammary vessels.
normalization factor was calculated as the mean contrast enhancement of the mammary
vessel voxels in the first contrast-enhanced frame. After normalizing the subtracted mean
intensity projection, regions showing contrast enhancement were extracted. Even if the
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contrast-enhanced frames were normalized, we have found that a fixed threshold was not
suitable to successfully segment lesions on all scans. At this step non-enhancing regions
have been removed by the subtraction with the pre-contrast frame and, when present, by
fat-saturation; therefore, the image histogram (in the breast and axillary regions) has a
peak around zero and the intensities of enhancing regions are located in the histogram
tail (Fig. 6.13). We combined the mean value, that is as closer to zero as many non-
enhancing areas are discarded by subtraction and fat-saturation, and the maximum value.
In particular, the maximum value is related to the maximum contrast uptake in the image
and it is chosen as the maximum value with a frequency of number of voxels at least
corresponding to 2 mm3 volume, thus avoiding to consider hyper-intense isolated voxels
due to noise or artifacts.
So, the global threshold TI was determined as:
TI = meanI +
maxI
3
, (6.3)
where meanI is the mean value of the normalized intensity histogram of the breast and
axillary region and maxI is the maximum intensity value observed in the same region.
Because lesions are often connected to feeding vessels, they are often segmented together.
To prevent lesion oversegmentation, which could reduce the diagnostic quality of the seg-
mentation and limit the performance of segmentation-based CAD applications, voxels be-
longing to vessels were excluded from lesion detection. For each voxel, the eigenvalues of
the covariance matrix were extracted, and the ratio between the highest and medium eigen-
values was used as a vesselness measure. Voxels with a ratio larger than a fixed threshold
Tv (where Tv = 10) were labeled as vessels and excluded from lesion detection. Con-
nected components were then extracted from the resulting mask (see Fig. 6.14. Connected
components were then extracted from the resulting mask.
6.3.1 False positive reduction
The regions showing contrast uptake include not only lesions (benign and malignant), but
also false positives such as skin, motion artifacts and noise.
A few heuristic criteria are applied in order to discard false positives.
First, regions with volume less than 20 mm3 are excluded; this roughly corresponds to a
lesion of 5 mm diameter, which is the cutoff for clinically relevant lesions, taking also into
account image resolution and possible lesion under-segmentation.
As reported in section 5.1, contrast-enhancement kinetics can be classified as curves I,
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(a)
(b)
Figure 6.13. Histogram (a) and log scale histogram (b) of the subtracted and normalized
mean intensity projection (breast and axillary regions) in the case of a study acquired without
fat-saturation. The dashed vertical line represents the mean value of the histogram, while
the blue rectangle identifies the intensity range of contrast-enhancing regions.
II and III with an increasing probability of malignancy (6%, 64%, and 87%, respectively)
[48]. However, these curves are referred only to individual voxels or set of contiguous voxels
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(a)
(b) (c)
Figure 6.14. (a)Maximum intensity projection of the second post-contrast subtracted frame,
in the case of a study acquired with fat-saturation. (b) 3D view of the mask obtained after
thresholding the normalized subtracted mean intensity projection. (c) 3D view of the same
mask shown in (b), after application of the vessel detection step based on the eigenvalues
of the covariance matrix. Many structures have been recognized as vessels and discarded, in
particular vessels connected to the lesion.
(typically formed by a few voxels) belonging to a single part of tissue having uniform vas-
cular characteristics, and thus having homogeneous contrast-enhancement. In particular,
we defined an homogeneity parameter as:
H =
image intensity standard deviation
mean image intensity
, (6.4)
and we found that it could be used to discriminate tissues having (H < 0.02) or not having
(H > 0.02) uniform vascular characteristics.
On the other hand, the average intensity curve calculated over an entire lesion (typically
not having homogeneous vascular characteristics) is generally more similar to the average
signal intensity curve shown in Fig. 6.15.
Thus, our aim was to identify trends which are indicative of structures other than benign
and malignant lesions, such for example noise, artifacts or vessels. Empirically, some simple
kinetic features were found to identify trends different from lesions, but rather typical of
vessels or artifacts, as shown in Fig. 6.15.
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Figure 6.15. Mean intensity curves calculated over an entire connected component in the
case of a lesion (black), a vessel (red) and an artifact (green).
For instance, artifacts due to noise and patient motion are usually characterized by high
signal variations; hence, regions with standard deviation of image intensity greater than
150, or with a higher-than-10% decrease or increase in signal intensity in the last frame,
with respect to the second-last frame, were discarded.
Furthermore, regions with mean intensity decreasing from the first to the second frame are
discarded as this pattern was found present in vessels but not in lesions.
6.4 Results
6.4.1 Statistical analysis
The results of the registration and breast segmentation steps were visually inspected by a
radiologist with more than 4 years of experience in breast MRI. The radiologist labeled a
finding as a true positive if the lesion was confirmed at histology or at follow-up, otherwise
it was defined as a FP. Detection rate was calculated as the number of true positives
(both malignant and benign) over the total number of lesions as defined at the reference
standard, whereas sensitivity was calculated as the number of malignant lesions detected
by the system over the total number of malignant lesions. Lesions were grouped according
to size as follows: from 5 to 10 mm, 11 to 20 mm, and larger than 20 mm [65] and
detection rate and sensitivity were calculated for each group. Sensitivity and detection
rate values are presented with 95% confidence intervals (CIs) using the Wilson method for
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single proportions. Detection rate and sensitivity were also separately calculated for fat-
sat and non-fat-sat exams, and the χ2 test was used to assess differences between the two
subgroups. The detection rate of the system for lesions satellite to index cancers detected
by radiologists for which a lesion-by-lesion pathological analysis was not reported, was
analyzed separately. FP findings were defined by the radiologist as mammary or extra-
mammary findings, and characterized either as vessels, image artifacts (i.e., skin, chemical
shift, patient movements, etc), lymph nodes, normal gland or other findings (i.e., nipple,
pectoral muscle, heart, etc). The FP median, 1st and 3rd quartiles were calculated for the
entire testing set, for the fat-sat and non-fat-sat subgroups. A two-sided Kruskal Wallis test
was applied to test for differences between the medians for the total number of FP/patient.
A P-level lower than 0.05 was considered statistically significant.
6.4.2 Results
Algorithm performance was evaluated on a dataset of 48 DCE-MRI studies performed on
women with suspicion of breast cancer based on conventional imaging. Relevant demo-
graphic, clinical and technical information on the dataset is shown in the flow chart in
Fig.5.4. The median of the largest diameter of benign and malignant lesions was, respec-
tively, 6 mm (range, 5-15 mm) and 26 mm (range, 5-75 mm). Overall, there were 16 lesions
sized 10 mm or less, 15 lesions between 11 and 20 mm, and 34 lesions sized larger than
20 mm. The automatic algorithm detected 58 of the 65 lesions (89% detection rate; 95%
CI 79-95%), including 52 of the 53 malignant lesions (98% sensitivity; 95% CI 90-99%).
Detection rate and sensitivity according to lesion size are shown in Table 6.1. In the fat-sat
Table 6.1. Number of Lesions and Performance for Each Dimension Group. Lesions were
grouped according to the National Cancer Institute. Detection rate and sensitivity were
calculated with a 95% confidence interval.
Lesion
Dimension
(mm)
#
Malignant
#
Benign
#
Total
Detection Rate
(Upper-Lower
Limits; 95% CI)
Sensitivity (Upper-
Lower Limits; 95%
CI)
5-10 6 10 16 69% (44%-86%) 100% (61%-100%)
11-20 13 2 15 87% (62%-96%) 92% (67%-99%)
>20 34 0 34 100% (90%-100%) 100% (90%-100%)
Total 53 12 65 89% (79%-95%) 98% (90%-99%)
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subgroup, 20 of the 25 lesions (80% detection rate; 95% CI 61-91%) were detected, includ-
ing 19 of the 20 malignant lesions (95% sensitivity; 95% CI 76-99%). In the non-fat-sat
subgroup, 38 of the 40 lesions (95% detection rate; 95% CI 84-99%) were detected, includ-
ing all 33 malignant lesions (100% sensitivity; 95% CI 90-100%). Differences in sensitivity
and detection rate between the two groups were not statistically significant (P=0.798 and
P=0.137 respectively).
A total of 7 lesions with an average size of 7±3 mm (mean±SD) were missed by the algo-
rithm, including 6 benign and 1 malignant nodules. Five of the undetected lesions were in
dataset A including: 2 fibroadenomas, 2 small enhancements with a negative MRI follow-
up of 5 and a 7 mm in size, respectively, and a 12-mm invasive ductal carcinoma. Missed
lesions in dataset B were two 5 mm small enhancements unchanged at MRI follow-up. Ex-
amples of lesions detected and missed by the system are shown in Figure 6.16. In addition
to malignant lesions histologically confirmed as a result of a lesion-by-lesion analysis in the
pathological report, 17 lesions satellite to malignant index lesions, with a median diameter
of 7 mm (range, 5-20 mm) were detected by two radiologists. Sixteen of them (94%) were
detected by the system. Median mammary FPs per breast were 4 (1stâĂŞ3rd quartiles
3-7.25), while median extra-mammary FPs per study were 2 (1st-3rd quartiles 1-5). Table
6.2 shows the distribution of findings according to the type. For the fat-sat subgroup, me-
dian mammary FPs per breast were 4 (1st-3rd quartiles 2-7.25); median extra-mammary
FPs per study were also 4 (1st-3rd quartiles 3-6). In the non-fat-sat group, median mam-
mary FPs per breast were 4.5 (1st-3rd quartiles 3.5-7), while median extra-mammary FPs
per study were 1 (1st-3rd quartiles 1-2). No statistical significant differences were detected
between the two subgroups (P=0.72).
Average execution time was 5m48s for the non-fat-sat group and 8m48s for the fat-sat
Table 6.2. Classification of FP findings according to the type.
Type # %
vessels 267 54
artifacts* 113 23
gland 80 16
lymph nodes 2 0.4
other° 32 6
* i.e. chemical shift, skin, patient movements.
°i.e. nipple, pectoral muscle.
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Figure 6.16. Examples of segmentation results, superimposed on the normalized and sub-
tracted mean projection over time. (a) A 33-mm invasive ductal carcinoma (fat-sat image)
correctly segmented; (b) a 7-mm invasive ductal carcinoma (fat-sat image) correctly seg-
mented; (c) a 26-mm invasive ductal carcinoma (non-fat-sat image) correctly segmented;
(d) a 25-mm invasive ductal carcinoma (fat-sat image) correctly segmented; here a 5-mm
satellite lesion (arrow) was missed by the system.
group. Execution time was measured on a computer equipped with a CPU Intel Core i7
940 Quad Core @#2.93GHz architecture and 8 GBytes RAM.
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Chapter 7
Breast lesion discrimination
Lesion discrimination is a diagnostic stage in the CAD pipeline dedicated to recognize
the level of malignancy of previously detected lesions. Breast DCE-MRI allows to depict
differences between malignant and benign lesions according to morphological and contrast-
enhancement kinetics features of lesions. Morphological attributes such as irregular or
spiculated margins, irregular shapes, heterogeneous and peripheral internal contrast en-
hancement are important indicators of malignancy [72]. Signal-to-time curves with rapid
decreasing of signal intensity after peak enhancement, reached approximately 2 or 3 min-
utes after contrast injection, are more frequently found in malignant lesions, whereas be-
nign lesions have typically slow persistent enhancement increase [72]. Figure 7.1 shows an
example of a malignant lesion with irregular margins and heterogeneous internal enhance-
ment and a benign lesion with regular margins and homogeneous internal enhancement.
Clinical interpretation of the kinetic and morphological properties is subjective and qual-
itative, therefore several studies have proposed computer assisted approaches. Gihuijs et
al. [73, 74] extracted morphological and kinetic features from lesions segmented manually
or semi-automatically after manual indication of a seed point and used linear discriminant
analysis and step-wise selection to select the best subset of features. Gibbs et al. [75] ap-
plied texture analysis based on Haralick features and used logistic regression analysis with
backwards elimination method to select the most discriminating subset of texture features.
Gal et al.[76] compared different classifiers (logistic regression, linear discriminant analysis,
bayesian and support vector machine) combining kinetic and morphological features, and
using an exhaustive search to select the best features.
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Figure 7.1. Examples of a malignant Invasive Ductal Carcinoma (IDC) (a) and benign
fibroadenoma (FAD) (b) breast lesions.
In the following a multiparametric model is presented, which combines a selection of mor-
phological and kinetic features for discriminating malignant from benign mass-like breast
lesions at DCE-MRI [77]. Original features are introduced and combined with features al-
ready presented in literature, with the aim of trying a different approach. Model selection
is performed by a genetic search [78] and a wrapper approach [79] using a support vector
regressor.
7.1 Methods
To validate the method, 73 mass-like lesions were retrospectively used. Lesions were de-
tected in 51 exams acquired at two centers at 1.5 T with MRI protocols described in 5.4
and confirmed by histopathology (54 malignant and 19 benign). Lesions were automat-
ically segmented after image normalization and elastic registration of contrast-enhanced
frames, as described in the previous steps, and then selected by two experienced radiolo-
gists in order to exclude non mass-like lesions or blood vessels. Lesion size was 13±8.4 mm
(mean±standard deviation) for benign lesions and 16.1±14.7 mm) for malignant lesions,
with lesion size determined as the longest diameter measured by radiologists. 33 lesions
had a size smaller than 10 mm (22 malignant, 11 benign), whereas 40 lesions had a size
larger than 10 mm (32 malignant, 8 benign). Table 7.1 summaries lesions histology. For
each lesion, a set of 19 features were automatically extracted: 10 morphological features,
related to shape, margins, and internal contrast-enhancement distribution, and 9 kinetic
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Table 7.1. Histological types for the 73 lesions included in the dataset.
Malignant Lesions Benign Lesions
Invasive ductal carcinoma (IDC) 36
Invasive lobular carcinoma(ILC) 4 Fibroadenoma (FAD) 9
Ductal carcinoma in-situ (DCIS) 4 Papilloma 4
Mixed Invasive Carcinoma 10 Other benign lesions 6
Total 54 Total 19
features computed from signal-to-time intensity curves. Two morphological features related
to the lesion shape are calculated on the binary mask: circularity [73] and convex index
[80]. Three features are used to describe the margin of a lesion: irregularity [73], mean
and standard deviation of angles between surface normals (( mean(ABSN), std(ABSN))
[81]. Other five features characterizing the internal enhancement pattern are extracted:
the autocorrelation function (evaluated at 2mm displacement), two features related to the
peripheral uptake and the mean and standard deviation of the shape index(SI)47 com-
puted inside the segmented mass. Enhancement kinetics features are used to characterize
the time course of signal intensity through the contrast enhancement defined as:
C(r, j) =
S(r, j)− S(r,0)
S(r,0)
j = 1, .., N (N =
5
6
) (7.1)
where S(r, i) is the intensity at voxel location r at time frame i and it is normalized to
the contrast enhancement of mammary vessels. Two types of features are derived from the
contrast enhancement. The first type is related to the fitting of the contrast enhancement
to the following analytical exponential function:
C = At exp(−tD) (7.2)
where the coefficients A and D control the function amplitude and decay, respectively.
These coefficients characterize therefore the contrast uptake and washout inside the le-
sion. The lesion uptake and washout of contrast material were characterized by fitting
the contrast enhancement C(r, i) with an analytical function rather than using a two-
compartmental pharmaco-kinetic model [83]. The use of a pharmaco-kinetic model implies
strict constrains in the acquisition protocols [84], that were not fulfilled in the acquisition
of many clinical datasets. Although, the analytical function proposed (Eqn. 7.2) cannot
model physiologically the lesion, its simple form allows for relaxing constrains on the ac-
quisition protocols still characterizing the kinetic behavior of the lesion.
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The second type of feature computes the area under the contrast enhancement curve C(r, t),
AUCEC. This feature is related to the total amount of contrast material in the lesion tis-
sue. The mean, standard deviation and entropy were computed in the lesion segmented
volume, yielding a total of 9 contrast enhancement kinetic features.
A support vector machine (SVM) was trained with feature subsets selected by a genetic
search. Best subsets were composed of the most frequent features selected by majority
rule. The performance was measured by receiver operator characteristics (ROC) analysis
with the 10-fold cross-validation method that prevents optimistically biased evaluations
due to overfitting. The bootstrap technique was used in order to estimate the confidence
interval of area under ROC (AUC) and to compare the classification performances of the
different features subsets. A Wilcoxon matched pairs one-tailed test was also performed
to determine the significance level of the performance improvement.
7.2 Results
Figure 7.2. ROC curves associated to the feature subsets selected in separated genetic
searches for each class of features and to the features subset selected by the genetic search
using all two classes of features.
Figure 7.2 shows the mean ROC curves related to the feature subsets selected in sep-
arated genetic searches for each class of features and to the features subset selected by
the genetic search using both classes of features. The AUC obtained in the three genetic
searches were 0.90±0.06 (mean±standard deviation) for the morphological features subset,
0.87±0.06 for the kinetic features subset, and 0.94±0.03 with the combined feature sub-
set. The AUC resulted from the combined feature subset was significantly higher (p-value
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< 0.01) than those obtained with the other feature subsets, showing that the combina-
tion of features increases the classification performances. Three morphological features
( mean(ABSN), std(ABSN), peripheralUptake) and three kinetic features (mean(D), en-
tropy(D), entropy(A)) were selected in separated genetic searches for each feature class.
Four features (mean(ABSN), std(SI), mean(D), mean(AUCEC)) were selected from the
combined use all two classes of features.
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Conclusions
The fully automatic algorithm we developed for breast lesions detection and characteriza-
tion in DCE-MRI has a high performance and is versatile as it can be used with different
equipment and acquisition modes.
The lesion detection system achieved a sensitivity of 98%, with an acceptable number of
FP findings. Moreover, the good performances obtained in detecting satellite lesions (16 of
17 were identified) highlights the system’s potential in helping the detection of multifocal
and multicentric breast cancers.
Fully automatic lesion detection has the potential of reducing inter- and intra-observer vari-
ability and reading time [42, 43, 44]. However, few methods have been developed to date
to detect breast lesions automatically with DCE-MRI. Ertaş et al developed an automatic
algorithm for the detection of breast lesions based on cellular neural network segmenta-
tion and 3D template matching [45]. They assessed the performance of their system on a
dataset of 39 lesions, of which 19 were benign and 20 malignant. All MRI studies were
performed with non-fat-sat sequences and they obtained a detection rate of 100% with less
than one FP per study. An automatic lesion detection method based on support vector
machine, proposed by Twellmann et al also showed promising results, yielding an area
under the ROC curve of 0.98. However, the algorithm was tested on a limited dataset of
12 patients and only on non-fat-sat images [46]. The above mentioned methods cannot be
applied to fat-sat images as normalization is performed by dividing each enhanced images
by the unenhanced one. This process yields very noisy images if fat-sat is applied, as most
of the breast signal is suppressed in the unenhanced frame. Moreover, Ertas et al applied
a fixed threshold to extract suspicious areas and this may limit the applicability to studies
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acquired with different protocols.
Our algorithm takes advantage of the following two innovative approaches. First, the
normalization technique we proposed is based on the contrast enhancement of mammary
vessels. Compared with normalization with respect to the unenhanced image, our approach
gives stable results in the case of fat-sat images, as the obtained normalization factor is
related to contrast agent administration. However, this method requires that DCE-MRI
is performed on the axial plane, as the mammary vessels should be included in the field
of view with an adequate spatial resolution. Second, we adopted the mIPT instead of
the commonly used MIPT (maximum intensity projection over time), because it is less
sensitive to noise and it produces more reliable segmentation. There are some limitations
to our method. First, the detection was obtained using the mIPT and this process could
underestimate lesion size, as late enhancing voxels and voxels with a rapid washout can
be attenuated when averaging over time. For the step of malignancy discrimination, a
more accurate identification of lesion boundary and morphology could be useful, and a
further refinement of the lesion segmentation may become necessary. However, using the
MIPT also has limitations. It affects the number of FPs negatively, as it is very sensitive
to artifacts and noise, and may lead to overestimation of lesion size due to the “blooming
sign”effect [66, 67, 68]. Second, our system has a higher number of FP findings if compared
with other academic software and to commercially available solutions [69]. Most of our
FPs are vessels, mainly tortuous vessels or bifurcations with low vesselness values. Detec-
tion of bifurcations is a known topological problem for vessel identification and tracking
[70, 71]. Reduction of the number of FPs can conceivably be obtained by introducing a
classification stage dedicated to the recognition of vessels, and more specifically of bifurca-
tions. This stage is ongoing, and it consists in a fully automatic step to detect vessels in
both fat-sat and non-fat-sat images. The algorithm consists of two main steps: a) linear
structure detection, with a multi-scale analysis based on a second order image derivatives,
and b) false positive reduction, based on the covariance matrix. We evaluated the algo-
rithm performance on a testing set, composed of 33 patients coming from two different
clinical centers. The system is showing promising results, evaluation and it could certainly
be used to improve the specificity of the CAD system. Improving the accuracy of breast
segmentation may also help reduce the number of FP findings. FP reduction is achieved
by a set of simple heuristics criteria based on knowledge of the morphological and kinetics
properties of FPs. A more efficient classifier could improve the system’s FP rate.
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On the other side, the classifier here proposed is able to discriminate malignant from be-
nign breast mass-like lesions using two groups of features (morphological and kinetic), and
obtaining a AUC of 0.94±0.03. The AUC for the feature selection (FS) resulting from the
combination of all two feature groups was significantly higher than those obtained with
all other selected FSs, showing that the combination of features increases the classification
performances. A genetic algorithm was used to select feature subsets, in order to prevent
unnecessary computation, overfitting, and to ensure a reliable classifier. The main limita-
tion of the discrimination step is the limited number of lesions. This can produce overfitting
of the training data, leading to overestimate the classifier’s performance. In order to re-
duce these effects, the total number of features was limited to 19 and the selected feature
subsets were composed only of 3 to 4 features. Moreover, classification performances were
evaluated with a stratified 10-fold cross-validation method to reduce the classification bias.
Another limitation is the unbalanced dataset. The number of malignant lesions is higher
than benign lesions, leading to a possible bias in the discrimination of malignancy. This
problem was partially reduced by presenting at training the same number of malignant
and benign lesions using copies of benign lesions. Nevertheless, the benign class can be
poorly described in the feature space.
In conclusion, the proposed CAD system was tested on MR datasets obtained from differ-
ent scanners, with a variable temporal and spatial resolution and on both fat-sat and non
fat-sat images, and has shown promising results. This type of system could potentially be
used for early diagnosis and staging of breast cancer to reduce reading time and to improve
detection, especially of the smaller satellite nodules. Further refinements are ongoing to
improve vessel detection, breast segmentation, and to validated these conclusions on a
larger dataset, including also non-mass like lesions.
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Part II
Developing a computer aided
diagnosis system for detection of
prostate cancer using multispectral
MRI
Prostate cancer (PCa) is the most common malignancy affecting men in the world, and
represents the third cause of cancer death in industrialized countries [8, 9, 10]. Over the
past two decades, prostate cancer diagnoses have become more common as a result of the
aging population and the widespread use of screening tests. Whenever PCa is suspected,
patients undergo biopsy guided by transrectal ultrasonography (TRUS). When cancer is
confined to the gland patients are usually submitted to prostatectomy or undergo radiation
therapy; a combination of radiation therapy, hormone therapy and chemotherapy is the
preferred treatment in patients with advanced PCa. Five-year survival rate is high, being
respectively 94.8% and 90% [85, 86].
There are several limitations to the currently applied diagnostic-therapeutic workflow,
which can be summarized as follows:
1. Prostate-specific antigen (PSA) test has a low specificity in detecting PCa; common
conditions, such as benign prostatic hyperplasia and prostatitis, also increase PSA
levels. In [87] 19970 men that were screened with PSA, 2692 had PSA levels greater
than 4.0 g/L, a widely used cutoff value for a positive screening result, but only 756
had prostate cancer (28%). Potential harms of PSA screening include: additional
medical visits, adverse effects of prostate biopsies, anxiety, and over-diagnosis (e.g.
the identification of prostate cancer that would never have caused symptoms in the
patient’s lifetime) leading to over-treatment with its associated adverse effects.
2. TRUS-guided biopsy has a low detection rate and low-specificity. Sextant biopsy
has a high false-negative rate, approaching 30% when using extended biopsy schemes
with retrieval of 10 to 12 cores [88]. Detection rate does not increase with repeated
biopsies; on the opposite, sensitivity is reduced at the 2nd and higher rounds of
biopsies [89].
3. Because of the lack of techniques for precise prostate cancer localization, current
treatment strategies involve the whole gland. Due to the inherent risks associated
with surgical resection and radiotherapy, many patients develop severe side effects
(table 8.1) [90]. New and less invasive alternatives are now available for localized
cancer, such as high intensity focused ultrasound (HIFU) or cryotherapy, but they
require accurate imaging tools.
Magnetic Resonance Imaging (MRI) has shown promise in localizing PCa, because of
its intrinsic high soft-tissue resolution. T2-w images allow clear visualization of the prostate
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Table 8.1. Adverse events of radical prostatectomy and radiotherapy.
Radical Prostatectomy Radioteraphy
Bowel urgency 15% 32%
Urinary leakage 62% 34%
Erectile dysfunction 84% 77%
anatomy; the central lobe can be easily distinguished from the periphery of the gland, and
the capsule is clearly discernible as a thin dark linear structure. Dynamic Contrast En-
hanced MRI (DCE-MRI) captures T1-w images while a dose of contrast agent is injected
and tumors can be detected since they usually show a distinctive early signal enhancement
and washout of signal intensity in the delayed phases. Magnetic Resonance Spectroscopy
(MRS) extends the possibilities of MRI to detect PCa by allowing assessment of molecular
constituents of the tissue, especially of choline, which is in higher concentration in tis-
sues with a high cellular metabolism [12]. Finally, Diffusion Weighted Imaging (DWI) can
measure the diffusion of water molecules in tissue and hence provide information on the
structural organization of the tissue. However, each MR approach alone has some draw-
backs, which can be implied from the large range of sensitivity and specificity variations
reported in the literature, only partially explained by the different diagnostic criteria used
in the various study [12, 13]. Recently it has been shown that combining 2 or more MR
modalities (such as for example T2-w and DCE-MRI) improves the sensitivity by almost
15%, bringing it up to 83-87% for tumors measuring 5 cm3 or more[14]. However the more
variables are introduced the more difficult it is even for the experienced reader to integrate
all the available information into one reliable final report. Complex problems, such as the
one reported in the previous paragraph, have been approached by developing computer
aided diagnosis (CAD) systems that aid the radiologist in diagnosing disease. The aim
of this part of the thesis was to develop a CAD system for detecting PCa, integrating all
information available from the different MR sequences. By overcoming the limitations of
the current subjective way of analyzing MR data, this approach could substantially modify
the diagnostic and therapeutic work-up of individuals with PCa (Fig. 8.1). This could
improve quality of patient’s life dramatically.
Advantages are summarized as follows:
1. Individuals with high PSA values and a negative CAD-MR exam could avoid core-
biopsies, thus reducing anxiety, the diagnostic delay of a false-negative finding, pro-
cedure related complications and the adverse events linked to overtreatment.
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Figure 8.1. A new work-up for prostate cancer
2. In case of a positive finding, CAD-MR could be used to perform biopsy under MR
guidance by using a specifically designed, commercially available medical device.
This would increase the accuracy of the procedure. Furthermore, biopsy could allow
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us not only to confirm the diagnosis of PCa but also possibly to identify tumor areas
having a different grading.
3. Imaging guided procedures, such as cryotherapy or MR guided High Intensity Fo-
cused Ultrasound (MRgFUS) could be performed having accurate color parametric
3D maps of the tumor available to plan treatment. MR can monitor temperature
or changes in diffusivity within the area of treatment if the procedure is performed
directly in the MR unit, as is the case of MRgFUS.
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Chapter 9
MRI sequences for multispectral MR
imaging of the prostate gland
9.1 Defining a protocol for MRI acquisition
T2-w images are considered to be the workhorse images for PCa, and to optimize them,
several T2-w images have been acquired on a dedicated phantom with different geometrical
settings. Images have been then analyzed to identify those with the best trade off between
spatial resolution and signal to noise ratio (SNR). Ideally, as T2-w images are also used as
the morphological reference for the remaining MR sequences, all of the subsequent images
should be acquired with the same geometrical setting as the T2-w acquisition. However,
due to the scanner limitations, a compromise between spatial and temporal resolution has
been necessary.
The DCE-MRI study must have a sufficiently high temporal resolution to obtain quan-
titative parameters from the dynamic curve fitting, and for this project 13 seconds have
been proven to be sufficient in order to fit in the bi-compartmental model (or Toft model)
without losing a large amount of anatomical information. Perfusion and permeability of
the cancer vessels, in fact, can be investigated only provided that the sequence is fast
enough to track such rapid physiological phenomena. Slow sequences are not indicated for
this kind of studies, in fact a reduced temporal resolution results in significant errors in
pharmacokinetic parameters, which may lead to an incorrect classification of the tumor
kinetics.
Brownian motion of water in organs varies according to tissue characteristics and can be
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estimated by means of DWI MR sequences. In this kind of acquisition the b-value is
the crucial parameter; if it is not properly set the subsequent results may be erroneous.
However, with this sequence it is necessary to reach a compromise between a b-value high
enough to distinguish tumoral tissues, without dramatically decreasing the SNR, that is
strictly correlated with the b-value. Considering that, two b-values 600 mm/s2 and 1000
mm/s2  have been chosen.
9.2 MRI Protocols
The dataset is composed by 23 patients, 4 of them were part of the training set, the remain-
ing 19 have been used to test and validate the algorithm. All studies have been acquired
on a 1.5 Tesla (T) scanner (Signa Excite HDx, General Electric Healthcare, Milwakee, WI)
using an endorectal radiofrequency coil.
DWI images have been acquired using a single-shot EPI sequence with the following techni-
cal parameters: FOV=16 cm, slice thickness 3 mm, pixel size=0.625 mm, BW=62.50 kHz,
TR=7000ms, TE=92.8 ms, flip angle=90°, 256x256 matrix, b-value=600 s/mm2, NEX=6,
24 slices. Apparent diffusion coefficient (ADC) values were calculated from two DWI im-
ages acquired with b-value=0 s/mm2 and 600 s/mm2.
T2-w images have been obtained using a fast recovery fast spin echo sequence with FOV=16
cm, slice thickness 3 mm, pixel size=0.3125 mm, BW=22.73 kHz, TR=3020 ms, TE=96.24
ms, flip angle=90°, 512x512 matrix, 24 slices.
For the DCE-MRI sequence the chosen protocol required a FAST spoiled gradient recalled
echo sequence with the following parameters: FOV=16 cm, slice thickness 3 mm, pixel
size=0.3906 mm, BW=83.33 kHz, TR=3.6 ms, TE=1.3 ms, flip angle=20°, 512x512 ma-
trix, 24 slices. After the precontrast acquisition, patients were given 0,1 cc/kg gadobutrol
(Gadovist) intravenously through a peripheral line at 2 ml/s, followed by an infusion of 20
cc normal saline at the same velocity. For each patient a total of 26 phases were acquired
sequentially, each lasting 13 seconds.
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Chapter 10
Registration
The first step for developing a CAD system, using multispectral MR images, is to perform
an automatic image registration step to correct for misalignment between images coming
from different MR sequences. Image registration is the process of finding a geometric
transformation between the two respective image-based coordinate systems that maps a
point in the first image set to the point in the second set that has the same patient-based
coordinates. Registration should correct for voluntary and involuntary (breathing, hearth
beating) movements during the dynamic acquisition (DCE-MRI), as well as for image
distortion due to the magnetic susceptibility in the DWI images.
10.1 Registration between T2-w and DWI images
As previously said, DWI has extreme sensitivity to motion and, consequently, requires ul-
trafast imaging techniques, such as the single-shot echo planar imaging (EPI), in which an
image is acquired within a single shot, thus during around 100 msec, and hence it is able to
froze the motion during the acquisition. EPI, however, is affected by geometric distortions
and chemical shift artifacts caused by the susceptibility effects. These effects are due to
the air-filled balloon surrounding the endorectal coil and poor local B0 homogeneity which
leads to pixel shifts, particularly in the phase encode direction. Jezzard [92] proposed a
method to correct geometric distortion which requires the measure of the magnetic field
map inside the FOV with the object to scan in place. Such a field map will include the
effects of inhomogeneities of the main magnetic field and varying tissue susceptibility, then
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values from the field map can then be compared with the expected values and the dis-
tortion calculated and corrected. This method achieved good performance but is difficult
to implement in normal clinical practice. Other methods are semi automatic and require
the manual placement of control points on both T2-w and DWI acquisition [91, 93]. In
this section a new fully automatic method to register T2-w and EPI-DWI images which
does not require the estimation of the static magnetic field and which is based on the
automatic segmentation of the bladder and the endorectal coil will be presented. Blad-
der and endorectal coil are well-defined structures in both T2 and DWI and are easy to
segment, while automatic prostate segmentation is challenging due to the heterogeneity of
this anatomical region.
10.1.1 Methods
The entire registration procedure involves two major steps. First, an affine transform
is estimated by a segmentation-based method. In this step the bladder is automatically
segmented in the DWI image by a watershed algorithm applied on the apparent diffusion
coefficient (ADC) map, where it is well visible because of its high water content. The
watershed is computed over the gradient magnitude image and proceeds in several steps.
First, an initial classification of all points into catchment basin regions is done by tracing
each point down its path of steepest descent to a local minima. Next, neighboring regions
and the boundaries between them are analyzed according to a saliency measure, which is,
in this case, the minimum boundary height, to produce a tree of merges among adjacent
regions. Then, excluding the background, the bladder is the biggest region obtained with
an absolute minimum height percentage of 10% and a depth of the catchment basin of
30%. As the bladder segmentation on DWI is obtained, morphological erosion and dilation
are applied to extract a stripe around the border of the bladder (Fig. 10.1c). The stripe
thickness is 20 mm, so it always includes the bladder wall also on the T2-w image. Pixels
belonging to this stripe on the T2-w image were classified by a k-means cluster in two
groups according to their intensity values, and the segmentation of the bladder wall is
obtained, as is shown in Fig. 10.1e.
Then bladder border points on the T2-w and DWI are extracted from the binary masks
(Fig. 10.2) and coupled using the iterative closed points (ICP) algorithm (Fig. 10.3) in
the slice where the bladder reaches its biggest area. The coupled points are used to find,
by a least squares fitting, the affine transform parameters and then the transformation is
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Figure 10.1. a) Bladder on DWI image. b) Segmented bladder on DWI. c) Stripe around
bladder wall on DWI d) Bladder on T2-w image. e) Segmented bladder wall on T2-w image.
applied on the whole DWI image.
(a) (b)
Figure 10.2. Segmented bladder on the DWI image (a) and T2 image (b).
(a) (b)
Figure 10.3. Some of the bladder border points matched with ICP on DWI (a)
and T2-w (b) images.
The affine transform computed in the previous step can correct possible shearing, trans-
lational and scaling artifacts mainly caused by motion or by eddy currents (residual gradi-
ent field) formed in presence of a changing magnetic field [94], but do not correct non-linear
geometric distortion caused in large part by static magnetic field inhomogeneities near the
coil, and which is a major concern because most prostate tumors are localized in the
peripheral zone. Therefore the first rigid registration step is refined with a non-rigid regis-
tration step based on the coil segmentation. The coil is segmented both in T2-w and DWI
images by a region growing algorithm, starting from a seed point inside the coil which is
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automatically found by a circular Hough transform. Then, for each slice where the coil is
visible, two spline smoothing curves are fitted on the coil border points on the DWI and
T2-w images and used to estimate the displacement near the coil surface (Fig. 10.4). The
initial displacement is estimated as the difference between the upper points of these spline
curves, as shown in Fig. 10.4. Therefore the deformation field T is modeled as a piecewise
linear decay field along the vertical direction (Eq. 10.1), assuming that the pixel shifts
caused by magnetic field inhomogeneities occur particularly in the phase encode direction
[92] and decrease linearly with distance from the coil.
T (x) = 0
T (y) =
 di − k ∗ y 0 < y <
di
k
0 y > dik
(10.1)
where the coordinate system is shown in Fig. 10.4. The decreasing rate of the vertical
displacement k in (10.1) was chosen maximizing the overlap index described in the following
section on a training set. Then the estimated deformation field T is applied to the DWI
in order to correct the geometric distortion (Fig. 10.5).
Figure 10.4. Spline curves superimposed on DWI (left) and T2-w (right), and initial
displacement between DWI and T2-w near the coil.
(a) (b) (c)
Figure 10.5. a) Prostate on T2 image. b) Deformation field superimposed on DWI. c)
Deformation field applied on DWI.
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10.1.2 Validation
In order to validate the registration method, the peripheral zone (PZ), the central gland
(CG) and the whole prostate gland (TOT) were manually drawn by a radiologist on both
DWI and T2-w images. In Fig. 10.6 are shown, both superimposed on the T2-w image,
the outlines of PZ and CG binary masks drawn on DWI (red line) and the outlines of the
same regions drawn on the T2-w (green) before (Fig. 10.6(a)) and after (Fig. 10.6(b)) the
application of the registration method. Two performance indexes were calculated before
and after registration: the overlap index (OI), defined as the ratio between intersection
and union of the masks, and the mean surface distance (MSD).The training set was used
to find the optimal decreasing displacement rate (k in (10.1)) maximizing the overlap
index, then the algorithm was validated on the testing set described in section 9.2 . A
t-test is performed to evaluate the p values between OI and MSD values before and after
registration. The null hypothesis is that there is no difference between OI and MSD values
before and after registration, with a significance level of 0.05.
10.1.3 Results
Table 10.1 reports the MSD values and Table 10.2 the OI values for CG, PZ and TOT
before and after registration. P-values for MSD measurements for CG, PZ and TOT are
respectively 0.001, 0.0000005 and 0.000004, while p-values of OI measurements are 0.0002,
0.00000 and 0.00000006 respectively. All p-values are smaller than the significance level,
showing that the OI and the MSD obtained before registration are statistically different
from those obtained after registration.
(a) (b)
Figure 10.6. Manual prostate gland segmentation drawn on DWI(red) and T2 (green)
superimposed on T2, before registration (a) and after registration(b)
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Table 10.1. Mean Surface Distance (MSD) for CG, PZ, TOT zones pre- and post-
registration. ∆ represents the % difference between the MSD pre and post registration.
Patients CG
pre
(mm)
PZ
pre
(mm)
TOT
pre
(mm)
CG
post
(mm)
PZ
post
(mm)
TOT
post
(mm)
∆
CG
∆
PZ
∆
TOT
# 1 0.30 1.66 0.32 0.11 0.27 0.08 -63% -84% -75%
# 2 0.38 2.05 0.57 0.08 0.39 0.13 -79% -81% -77%
# 3 0.42 1.40 0.56 0.16 0.29 0.13 -62% -79% -77%
# 4 0.39 1.82 0.59 0.24 0.31 0.20 -38% -83% -66%
# 5 1.36 0.16 1.33 0.25 0.12 0.12 -82% -25% -91%
# 6 0.25 1.54 0.29 0.11 0.46 0.09 -56% -70% -69%
# 7 0.29 1.75 0.50 0.11 0.22 0.10 -62% -87% -80%
# 8 0.19 1.30 0.44 0.17 0.22 0.09 -11% -83% -80%
# 9 0.30 2.07 0.50 0.14 0.27 0.13 -53% -87% -74%
# 10 0.29 0.79 0.27 0.20 0.24 0.13 -31% -70% -52%
# 11 1.64 3.33 1.35 0.29 0.50 0.16 -82% -85% -88%
# 12 0.43 2.17 0.51 0.13 0.55 0.14 -70% -77% -73%
# 13 0.98 2.41 0.93 0.53 1.13 0.42 -46% -53% -55%
# 14 0.25 1.27 0.51 0.21 0.42 0.19 -16% -67% -63%
# 15 0.25 1.39 0.56 0.25 0.50 0.24 -0% -64% -57%
# 16 0.26 1.10 0.38 0.13 0.32 0.13 -50% -71% -66%
# 17 0.90 4.31 1.42 0.12 0.72 0.26 -87% -83% -82%
# 18 0.25 0.89 0.35 0.23 0.41 0.21 -8% -54% -40%
# 19 0.38 2.80 0.98 0.19 0.84 0.26 -50% -70% -73%
Mean 0.50 1.80 0.65 0.19 0.43 0.17 -50% -72% -70%
STD 0.42 0.95 0.37 0.10 0.25 0.08 26% 15% 13%
10.2 Registration between T2-weighted and dynamic con-
trast enhanced T1-weighted MRI
DCE-MRI, as it has been said in Section 3.5, is a widely used technique for quantitative
assessment of the vascular properties of tissue. Observing the rate of change of image
intensity in the presence of a gadolinium-based contrast agent allows inferences to be made
about the underlying vascular status. The pattern of enhancement yields quantitative
information that allows the assessment of pharmacokinetics in both single studies and
in sequential studies such as screening [95]. In this situation, motion artifacts can have
a strong influence on parameter estimation by causing apparently extreme changes in
enhancement. An explicit example is a non-enhancing location that at some time-point is
subject to motion that replaces the underlying tissue with that of tissue that has enhanced.
Therefore, the model-fit used during DCE-MRI analysis, may distort the enhancement
curve to accommodate this change. If the motion is early, the pixel will have a strong
wash-in and wash-out, potentially aliasing to pathological enhancement. Similarly for
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Table 10.2. OI for CG, PZ, TOT zones pre- and post- registration. ∆ represents the %
difference between the OI pre and post registration.
Patients CG
pre
PZ
pre
TOT
pre
CG
post
PZ
post
TOT
post
∆
CG
∆
PZ
∆
TOT
# 1 0.77 0.33 0.80 0.85 0.65 0.88 10% 97% 10%
# 2 0.73 0.30 0.72 0.87 0.62 0.85 19% 107% 18%
# 3 0.64 0.37 0.69 0.77 0.68 0.83 20% 84% 20%
# 4 0.73 0.35 0.71 0.77 0.72 0.83 5% 106% 17%
# 5 0.50 0.24 0.60 0.78 0.69 0.84 56% 187% 40%
# 6 0.76 0.31 0.79 0.84 0.53 0.87 10% 71% 10%
# 7 0.76 0.36 0.74 0.83 0.71 0.86 9% 97% 16%
# 8 0.80 0.44 0.77 0.80 0.72 0.88 0% 64% 14%
# 9 0.77 0.30 0.75 0.84 0.67 0.85 9% 123% 13%
# 10 0.76 0.55 0.78 0.79 0.71 0.84 4% 29% 8%
# 11 0.42 0.18 0.51 0.70 0.54 0.81 67% 200% 59%
# 12 0.73 0.29 0.73 0.82 0.53 0.84 12% 83% 15%
# 13 0.53 0.30 0.60 0.64 0.49 0.71 21% 63% 18%
# 14 0.77 0.49 0.74 0.75 0.67 0.83 -3% 37% 12%
# 15 0.77 0.46 0.73 0.73 0.64 0.81 -5% 39% 11%
# 16 0.78 0.49 0.77 0.82 0.65 0.84 5% 33% 9%
# 17 0.57 0.12 0.54 0.82 0.46 0.76 44% 283% 41%
# 18 0.74 0.51 0.76 0.76 0.68 0.81 3% 33% 7%
# 19 0.69 0.27 0.64 0.78 0.49 0.79 13% 81% 23%
Mean 0.70 0.35 0.70 0.79 0.62 0.83 16% 96% 19%
STD 0.11 0.11 0.08 0.06 0.09 0.04 19% 66% 13%
later motion artifacts, the enhancement curve may be distorted such that the pixel is
observed to enhance in a normal mode, particularly if the bolus arrival time is fixed. Thus,
parameter estimation depends strongly on the flexibility of the fitted model and its ability
to identify outliers resulting from either poor model choice or patient motion or both [96].
For these reasons the registration within the DCE sequence is a key point to develop a
system able to analyze parameters derived from the images during the contrast injection.
However, the aim of this part of the thesis was to develop a multispectral CAD system,
that should take informations coming from different dataset. Therefore, the main idea was
to register the whole dynamic sequence to the T2-w image. The advantages deriving from
using T2-w images as an additional MR modality to discriminate PCa from benign regions
in the peripheral zone (PZ) of the prostate has been widely studied [96], as they are also
used by the radiologist for localizing PCa. Notwithstanding, the challenge of using T2-w
images as reference in the registration step of a CAD system arises from adding a new
source of possible misalignment, and introduce differences between the two datasets that
should be taken into account (Fig. 10.7).
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(a) (b)
Figure 10.7. On the left: a slice from a T2-w volume. On the right: a slide from a
DCE-MRI acquisition. It is important to notice how the two images are different in terms
of spatial resolutions, signal intensity, field of view, and origin of the images.
10.2.1 Methods
Image preprocessing
To overcome the problem of having two dataset with different field of view (FOV), origin,
spatial resolution and signal intensities, some preprocessing algorithms have been devel-
oped as first step of this registration method.
As previously said (Section 9.1) T2-w images have a higher spatial resolution than the
DCE-MRI sequences, thus having a smaller field of view (FOV). The slice thickness is 3
mm for both dataset, while the pixel size is 0.3125 mm for T2-w images and 0.3906 mm
for the dynamic sequence. In order to register two dataset having the same FOV, the
T2-w images have been downsampled to the DCE spatial resolution. The downsampling
operation have been preferred to the upsampling of the dynamic sequence to avoid the in-
troduction of interpolated pixels in a volume where a pixel wise analysis will be performed
to detect and diagnose tumoral tissues. Hereinafter, each volume of the DCE sequence
need to be cropped in order to obtain the same FOV of the T2-w images. Even if in this
project the entire dataset belongs to one center, thus having the same scanner and using
the same acquisition parameters, the whole procedure is fully automatic, and takes the
spatial information from the dicom header, making the algorithm potentially able to work
with dataset coming from different scanners or acquired with different parameters.
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Secondly, in order to perform a registration between dataset having different image inten-
sities, it is necessary to find a set of similar features in the first image to a set of features
in the second image that are also mutually similar [97]. For example, according to the
principle of mutual information (see Sec. 10.2.1), homogeneous regions of the first image
set should generally map into homogeneous regions in the second set [98, 99]. However
due to the coil susceptibility and other sources of noise, the histogram of both T2-w and
DCE images have a tail of noisy pixels, that make the similarity measure less reliable.
In order to make the shape of the histogram more congruent, a threshold based on the
position of the 99% percentile of the images has been set (Fig. 10.8). In Fig. 10.9 results of
the preprocessing step applied on the T2-w and on three enhanced images of the dynamic
sequence are shown.
(a) (b)
(c) (d)
Figure 10.8. Histograms of the t2-w and DCE images. a) Original T2-w histogram; b)
Original DCE histogram; c) Thresholded T2-w histogram; d) Thresholded DCE histogram.
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(a) (b)
(c) (d)
Figure 10.9. Preprocessing step applied on the T2-w image (a),and on the first (b), seventh
(c) and fourteenth (d) enhanced images.
Affine transform
There are many different transforms algorithm studied and used for image registration,
from simple translation, rotation and scaling to general affine and kernel transform. For
prostate T1-w to T2-w image registration we found that the most suitable transform is
the affine, because it is able to consider also the shearing derived from the transrectal coil.
Affine transform is composed of rotation, scaling, shearing and translation. The transform
is specified by a N×N matrix and a N×N vector where N is the space dimension. Its main
advantage comes from the fact that it is represented as a linear transformation, and the
coefficients of the N×N matrix can represent rotations, anisotropic scaling and shearing.
Equation 10.2 illustrates the effect of applying the affine transform in a point in 3D space.
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
x′
y′
z′
 =

M00 M01 M02
M10 M11 M12
M20 M21 M22
 ·

x− Cx
y − Cy
z − Cz
+

Tx + Cx
Ty + Cy
Tz + Cz
 (10.2)
Registration metric
The metric component of a registration algorithm provides a measure of how well the fixed
image (in our algorithm the T2-w) is matched by the transformed moving (each DCE
volume) image, forming the quantitative criterion to be optimized during the iterative
process. As we previously said, if different modalities are involved, metrics based on direct
correlation of gray levels are not applicable, and a statistical measure need to be involved.
The chosen metric is the one based on the mutual information (MI) similarity, in particular
the one developed by Mattes [56]. The major advantage of using MI is that the actual form
of the dependency does not have to be specified. Therefore, complex mapping between
two images can be modeled. This flexibility makes MI well suited as a criterion of multi-
modality registration. Mutual information is defined in terms of entropy. Let
H(A) =
∫
pA(a) log pA(a)da (10.3)
be the entropy of a random variable A, H(B) the entropy of a random variable B, and
H(A,B) =
∫
pAB(a, b) log pAB(a, b)dadb (10.4)
be the joint entropy of A and B. If A and B are independent, then
pAB(a, b) = pA(a)pB(b) (10.5)
and
H(A,B) = H(A) +H(B). (10.6)
However, if there is any dependency, then
H(A,B) < H(A) +H(B). (10.7)
The difference is called Mutual Information: I(A,B)
I(A,B) = H(A) +H(B)−H(A,B) (10.8)
In Mattes MI implementation, only one set of intensity samples is drawn from the image.
Using this set, the marginal and joint probability density function (PDF) is evaluated
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at discrete positions or bins uniformly spread within the dynamic range of the images.
Entropy values are then computed by summing over the bins. Therefore the metric requires
two parameters to be fine tuned: the number of bins used to compute the entropy and
the number of spatial samples used to compute the density estimates. The number of
spatial samples can usually be as low as 1% of the total number of pixels in the fixed
image. Increasing the number of samples improves the smoothness of the metric from
one iteration to another and therefore helps when this metric is used in conjunction with
optimizers that rely of the continuity of the metric values. The trade-off, of course, is that
a larger number of samples result in longer computation times per every evaluation of the
metric. It has been demonstrated empirically that the number of samples is not a critical
parameter for the registration process. In the algorithm development the best compromise
on the time it takes to compute one evaluation of the Metric have been obtained using
the 5% of the total number of samples. On the contrary, the number of bins may have
dramatic effects on the optimizer’s behavior, the chosen value for this algorithm was 50
bins.
Since the fixed image PDF does not contribute to the metric derivatives, it does not need to
be smooth. Hence, a zero order (boxcar) B-spline kernel is used for computing the PDF. On
the other hand, to ensure smoothness, a third order B-spline kernel is used to compute the
moving image intensity PDF. The advantage of using a B-spline kernel over a Gaussian
kernel is that the B-spline kernel has a finite support region. This is computationally
attractive, as each intensity sample only affects a small number of bins and hence does not
require a N×N loop to compute the metric value. During the PDF calculations, the image
intensity values are linearly scaled to have a minimum of zero and maximum of one. This
rescaling means that a fixed B-spline kernel bandwidth of one can be used to handle image
data with arbitrary magnitude and dynamic range.
Multiresolution optimization strategy
The registration process is automated by varying the deformation in the test image (DCE)
until the discrepancy between the two images is minimized. We use a regular step gradient
descent optimizer, to reduce the cost function in until termination criteria are satisfied. The
gradient descent optimizer method is the most straightforward method for incorporating
gradient information in the minimization process [100]. The minimum of the function is
found by a number of consecutive 1-D line minimization steps, and each of this step starts
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at the minimum found in the previous step and proceeding in the direction of the gradient
at that point, i.e. the direction of the steepest descent.
In order to avoid local minima, and to decrease computation time, we use a hierarchical
multiresolution optimization scheme. We initially optimize for a deformation to recover the
gross motion of the patient and large anatomic structures. As we increase the resolution,
we recover increasingly fine misalignments. The spatial mapping determined at the coarse
level is then used to initialize registration at the next finer scale. This coarse-to-fine strategy
greatly improve the registration success rate and also increases robustness by eliminating
local optima at coarser scales. The registration pipeline for the multiresolution approach
is described in Fig. 10.10(a) where the image pyramids represent the set of downsampled
and smoothed fixed and moving images. Each level of the image is used for a single level
of the registration method (see Fig. 10.10(b)); in the method here presented the number
of resolution steps was set as 4.
(a)
(b)
Figure 10.10. Components of the multi-resolution registration framework
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10.2.2 Results
Validating the performance of an image registration algorithm with real images is not
straightforward. The lack of a gold standard complicates matters and prevents any auto-
mated assessment of registration accuracy. Even if individuals trained to interpret medical
images are involved in a validation experiment, providing a method for consistently as-
sessing individual images is difficult. There is a tradeoff between the number of images
that can be assessed and the time required to assess each one, a situation that often forces
researchers to validate algorithms based on a limited sample size. However the capacity of
the human eye to rapidly and accurately (albeit only qualitatively) determine the quality
of a registration should not be underestimated. While validation methods involving human
assessment will be prone to error, bias, and inconsistencies, if two images are presented
in a user-friendly manner, experienced physicians can rapidly assess the “gestalt”quality
of the registration in a short amount of time. Furthermore, they have a priori knowledge
of where in the anatomy the quality of the registration should be high and where these
requirements can be relaxed. An experienced radiologist blindly analyzed the registered
and non-registered images, having the possibility to draw region of interest on the images.
After the analysis of 10 patients the radiologist affirmed that the quality of the registered
images was superior than the quality of the non-registered ones. A more accurate vali-
dation will be done, analyzing the performances of the lesion classifier working with both
registered and non-registered images. The registration algorithm would be considered use-
ful if we will obtained a more robust classification using the registered images. In Fig.
10.2.2, 10.2.2 are shown some registration results.
10.3 Discussions
In this Chapter we presented two automatic registration algorithms able to correct mis-
alignment between T2-w, DWI and DCE images, due to a) incorrect determination of the
resonance frequency by the scanner in some measurements leading to a “rigid body” shift in
the phase-encoding direction of the echo planar images, b) susceptibility inhomogeneities
resulting in irregular distortions, e.g. proximal to rectal wall at the air-tissue interface,
and c) voluntary and involuntary patients movements during the acquisition.
To the best of our knowledge there are no methods in literature addressing the registration
between T2-w and DWI in an fully automatic way. De Souza et al. [91] corrected the
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displacement between by shifting the DWI images according to the amount of displaced
center of mass, manually calculated. Automatic methods have the potential of reducing
inter- and intra-observer variability and reading time, and could be integrated in a fully
automatic CAD system for prostate cancer detection and diagnosis. One limitation of
this method is represented by the choice of the parameters for the piecewise linear decay
modeling. These parameters are heuristic constants chosen in order to obtain the best per-
formance on the training set. Future works should include the choice of such parameters
based on a optimization step, i.e. including mutual information, in order to obtain more
reproducible results and better generalize the problem.
In conclusion, we presented a method to automatically register images coming from three
different datasets, and results showed a good overlap after registration and a strong decrease
of mean surface distance in both the central gland and peripheral zone. The algorithm
should be certainly tested on a larger dataset, but its promising results suggest that it
could be integrated in a CAD system which will combine the pharmacokinetic parameters
derived from DCE-MRI, T2-w MRI and DWI MR.
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(a)
(b)
Figure 10.11. Result of the registration between T2-w and DCE images. Above: a) T2-w,
b) non-registered frame 7 post-contrast, c) registered frame 7 post-contrast, b) non-registered
frame 14 post-contrast, c) registered frame 14 post-contrast. Below is represented the same
frame of the same patients, but in a different slice of the volume. The colored ROIs represent
the region of interest drawn by the radiologist on the T2-w image and superimposed on the
non-registered and registered images. It is noticeable the better overlap between the ROIs
and the anatomic region on the registered images.
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Figure 10.12. Result of the registration between T2-w and DCE images applied on an-
other patient. a) T2-w, b) non-registered frame 7 post-contrast, c) registered frame
7 post-contrast, b) non-registered frame 14 post-contrast, c) registered frame 14 post-
contrast. In this case patient’s movements are smaller and less evident, but it is still
significant a better overlap in the registered images.
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Lesions characterization
Having all the datasets registered, suspicious areas could be segmented, by representing
each pixel like a vector containing scalar values, such as T2-w image intensity, quantitative
physiological parameters (i.e. Kep, Ktrans) obtained from DCE-MRI datasets, and values
of apparent diffusion coefficient (ADC) maps obtained from DWI images.
The aim of this chapter is to present a fully automatic scheme for the discrimination of
malignant prostate lesion from healthy tissue, based on quantitative extraction of features
coming from DCE-MRI images. DCE-MRI may offer quantitative information about per-
fusion, vessel permeability, blood volume and interstitial volume. The main drawback
of this approach is that accurate pharmacokinetic modeling of DCE-MRI data requires
knowledge of the concentration of the contrast agent in plasma, which is generally difficult
to measure, largely because of limited temporal resolution, especially in a standard clinical
setting. Low temporal resolution causes systematic errors in model output parameters,
inter-patient variability and intra-patient variations between successive measurements. As
an alternative to this approach empirical functions can be used, avoiding any assumption
about tumor physiology.
The algorithm here presented will assess the probability of malignancy pixel-wise in a
predefined area of the prostate gland.
11.1 Methods
All DCE-MRI studies, previously described (Sec 9.2) were examined by an expert radiolo-
gist who drew, by using a self-made algorithm, a series of regions of interest (ROI) around
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the suspicious areas and on the opposite side of the gland on healthy tissue. Twenty areas
of prostate carcinoma, all located in the peripheral zone (PZ) of the gland, were detected
and contoured. The median tumor size was 61 mm2; range from 18 to 119 mm2. Benign
regions were selected for each patient in healthy PZ whose dimension was comparable to
that of the corresponding malignant tumor. Pixels belonging to the same selected ROI
were then extracted from each of the 26 series of images in order to construct the time-
intensity curves, hereinafter C(t) .
11.1.1 Time-intensity curves extraction and filtering
The signal intensities of pixels belonging to the same ROI were extracted from each of the
26 DCE volume acquisitions, to construct the time-intensity curves C(t) as
C(t) =
S(t)− S(0)
S(0)
(11.1)
where S(t) is the image signal intensity in each volume and S(0) is the precontrast signal
intensity. Subsequently a wavelet filtering operation was performed to reduce the noise
contribution. This step is composed by the following steps: a) 4th level signal decomposi-
tion using a 4th order Daubechies filter; b) threshold on the wavelet coefficients; c) inverse
transform to reconstruct the signal. Figure 11.1 shows an application of such signal de-
noising procedure. The signal to noise ratio (SNR) was estimated as the ratio between the
Figure 11.1. Example of the wavelet denoising result on a time-intensity curve.
power of the original signal to the power of the difference between the original and the
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denoised signal. Pixels with SNR lower than 10 dB were excluded from the analysis.
11.1.2 Features extraction
Bicompartmental Toft model [101][6], Eq. 11.2, was used to perform fitting on the remain-
ing curves to extract pharmacokinetic parameters ( ve, Kt, ke).
C(t)− vpCp(t) +Ktrans
∫ t
0
Cp(τ)e
−kep(t−τ)dτ (11.2)
where Cp is the CA concentration in the plasma, also called the artery input function (AIF),
Ktrans is the trans-endothelial transport of contrast medium from vascular compartment
to the tumor interstitium, kep is the transport parameter of contrast medium back into the
vascular space, ve is the extravascular-extracellular space fraction of the tumor, and vp is
the plasma volume fraction (ve + vp = 1). The AIF was computed by placing a ROI on
the iliac artery by an expert operator.
In addition to the pharmacokinetic model, the following two empirical functions were used
to fit C(t), without making any assumption about tumor physiology: the Weibull function,
Eq.11.3, and the Phenomenological Universalities (PUN) approach [102] in Eq. 11.4.
yweib(t) = At · exp(−tB) (11.3)
yPUN (t) = exp
[
rt+
1
β
(a0 − r)(exp(−βt)− 1
]
. (11.4)
The nonlinear curve fitting was solved in the least-squares sense with the Levenberg-
Marquardt algorithm, starting from an initial guess estimated with a grid parameters
search. Fitting goodness was evaluated using the determination coefficient (R2). Upper
and lower bounds of the model parameters were chosen to reflect physiological behavior
normally found in healthy and tumor tissues. Furthermore, some model-free features were
also derived from C(t): maximum uptake (MU), peak location (PL), defined as the frame
index at which the maximum enhancement occurs, uptake rate (UR) defined as MU/PL,
initial area under the curve C(t) (IAUC), calculated within the first 60 seconds after the
contrast injection, and washout rate (WR) defined as MU−C(tEND)tEND−PL , where tEND is the final
time point in the acquisition series. A total of 13 parameters were extracted for each pixel
in each ROI. The scatter plots of the most significant combination of features for Toft,
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Weibull, and PUN models are reported in Figure 11.2. A good separation between the
features describing the malignant curves and the benign ones can be observed in each of
the three parameter planes.
11.1.3 Features selection
The initial 13 features set was reduced in order to avoid over-fitting problems and to discard
redundant information. Therefore the best features were selected according to their area
under the Receiving Operator Characteristic (ROC) curve (Table 11.1). In couples of
highly correlated features the parameters with the smaller area under the ROC curve was
discarded 11.2.
Table 11.1. Area under ROC curves for each single parameters
Toft Non parametric features Weibull PUN
ve KT ke MU PL UR WR IAUC Aweib Bweib r β a0
0.6 0.86 0.86 0.72 0.88 0.85 0.81 0.53 0.89 0.90 0.83 0.79 0.85
Table 11.2. Area under ROC curves for each single parameters
(ke,Ktrans) (MU, UR) (UR, A) (MU, A)
0.81 0.83 0.93 0.87
11.1.4 Bayesian classifier
A 6-dimensional vector X = [KT ,PL,WR, Aweib, Bweib, a0] was generated for all of the
10964 pixels (5168 benign and 5796 malignant) whose model fitting did not fail (R2 ≥ 0.7).
Since the available dataset was not large enough to build two separated subsets, one for
the training and the other for the testing procedure, the performance of the algorithm was
estimated by exploiting the leave-one-out (LOO) method. The LOO involves training on
all but one patient, and testing on the left-out patient by estimating the likelihood of pixels
malignancy. The procedure was repeated until each case has been tested individually. In
each LOO step the training pixels were used to estimate the class-conditional probabilities
P(X|mal) and P(X|ben), assuming that the features come from a multivariate normal
distribution. The malignancy probabilities for the testing pixels were calculated with the
Bayes rule as stated in Eq.11.5
P (mal)|Xi) = Xi|P (mal)P (mal)
P (Xi)
(11.5)
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(a)
(b)
(c)
Figure 11.2. Scatter plots of three quantitative models implemented: (a) Toft (Ktrans, kep),
(b) Weibull (A, B), and (c) EU1 model (β, a0). Good separation between malignant and
benign points can be observed for the three combination of parameters shown.
where Xi is i-th feature vector associated to the i-th pixel, P (mal)=0.5 is the a priori
probability of malignancy assumed equal to the a priori probability of benignity, and
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P (Xi) = P (mal)P (Xi|mal) + P (ben)P (Xi|ben).
11.2 Results
Figure 11.3 shows the output ROC curve for the Bayesian classifier. The resulting area
Figure 11.3. ROC curve for the Bayesian classifier computed on a total of 10964 pixels
(5168 benign and 5796 malignant)
under the curve was 0.899 (95%CI:0.893-0.905); sensitivity and specificity were 82.4% and
82.1% respectively at the best cut-off point (0.352). Using only the three Toft parameters
(ve, KT , ke)the ROC area was equal to 0.879 (CI 95%:0.873-0.886). The difference between
the area under the ROC computed using the 6-dimensional vector and the Toft model alone
parameters is significant (p < 0.001)[103].Among the features here proposed, the Weibull-
ones show the better discriminating performance with respect to all the others (ROC area
= 0.896, 95%CI:0.889-0.902).
Figure 11.4 shows an example of the output probability map of a suspected lesion and a
healthy region.
11.3 Discussion
The Bayesian classifier here shown achieved good performances in discriminating between
benign and malignant regions in the prostate PZ. This system obtained a bigger area
under the ROC curve compared to the results of previous works available in literature
based on Toft model, leading to a better lesion detection rate. However, the classifier
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Figure 11.4. Output probability map computed on a suspected lesion as well as on
a healthy zone. Red color means a probability p>0.8, yellow: 0.66p<0.8, green:
0.46p<0.6 and blue:p<0.4.
performs a pixel-wise analysis without taking into account neighbor pixels, hence a possible
improvement will be the integration of information coming from a kernel analysis.
Moreover this system should integrate parameters obtained on T2-w and DWI image, in
order to perform a multispectral analysis, and should be test in a larger dataset, using
histological tumor maps as ground truth, but the promising results here obtained suggest
high likelihood to be successful.
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Monitoring local treatment using
Diffusion Weighted MR Imaging
In the proposed diagnostic-therapeutic path, once the lesion detection and characteriza-
tion have been obtained, a MRI guided biopsy could be performed, directing the biopsy
needles on the suspected region, thus avoiding random biopsies. In case of positive biopsy
and localized tumors (stage T1localized to one part of the body, and stage T2 locally
advanced ) a local treatment will be performed. Four modalities appear to have the most
clinical promise for prostate cancer focal therapy, including HIFU, cryotherapy, Radiation
Therapy (RT) and Photodynamic Therapy (PDT) (see Table 12.1).
12.1 Criotherapy
Interest in cryotherapy has been renewed as understanding of cryobiology has evolved
and newer cryoprobes have become available. Third-generation cryoprobes currently use
gas rather than liquid, allowing smaller diameter probes and a more conformal technique.
Cryotherapy is typically administered via the perineum under ultrasound guidance. Cell
destruction occurs primarily from disruption of the cellular membrane, leading to necrosis
and vascular thrombosis.
Based on available data, whole gland cryotherapy provides intermediate term biochemical
control in a reasonable proportion of patients but it results in a high rate of erectile
dysfunction. As a focal therapy treatment, feasibility has been shown but it has yet to
be formally or extensively studied. Cryotherapy may lack the requisite precision for focal
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Table 12.1. Focal therapy modalities
Focal therapy modalities
HIFU Cryotherapy Radiation
therapy
PDT
Mechanism Thermal induced
protein denatura-
tion + coagulative
necrosis
Disruption of cellu-
lar membrane + de-
layed vascular oc-
clusion
DNA damage, cell
damage apoptosis
Light activated,
oxygen dependent
effects vascular
occlusion
Application Transrectal with
cooling device
Transperineal apoptosis XRT,
brachytherapy
(removable or
permanent seed
implants)
Transperineal light
fibers
Available systems Ablatherm®,
Sonablate®500
AccuProbe®,
SeedNet™,
Cryocare®
Numerous Tookad in
phase I/II tri-
als for vascular
targeted
phototherapy
Retreatment Yes Yes Depends on dose
delivered to sur-
rounding normal
tissues
Yes
Limitations Treating anterior
tumors + small
prostates
Treating large
prostates
XRT (prostate mo-
tion + proximity of
bowel to target re-
gion), brachyther-
apy (large prostates
+ pts with signifi-
cant urinary symp-
toms)
Unknown
Anesthesia General or regional General or regional XRT (none),
brachytherapy or
HDR (general or
regional)
General or regional
Treatment moni-
toring
MRI or ultrasound Ultrasound + ther-
mosensors
CT, ultrasound,
fluoroscopy, cys-
toscopy
MRI or ultrasound
ablation with minimal disruption of normal function.
12.2 Radiation Therapy
RT has traditionally been administered to the entire gland by external beam or brachyther-
apy. Technological progress has allowed RT to be concentrated more selectively and re-
cently to dose intensify predetermined regions of the prostate. The ability to dose escalate
is notable since the likelihood of long-term cancer control is directly associated with the
radiation dose. Three-dimensional conformal therapy delivers the intended radiation dose
to the target area while limiting irradiation of critical surrounding structures, such as the
bladder and rectum.
Intensity Modulated Radiation Therapy (IMRT) further achieves these objectives by pro-
viding an unprecedented focal application of radiation dose to pre-specified areas. With
IMRT, Zelefsky et al achieved excellent long-term biochemical control rates while improv-
ing the toxicity profile by sparing adjacent organs from treatment related effects [104].
RT appears to be particularly suitable for study as a focal treatment option. It has an
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established biological basis, known tumoricidal activity, and familiarity to radiotherapists
and urologists. When applied as focal therapy its use remains investigational since the
effects of radiation scatter, long-term tumor control rates and ability to re-treat are un-
known.
12.3 Photodynamic therapy
In PDT a topically or systemically administered photosensitizer accumulates in a target
tissue, where it can be activated by light. Activation of the photosensitizer leads to the
generation of active radicals that are toxic to the tissue.Most current photosensitizers are
porphyrin derivatives that primarily target the cellular compartment of a tumor. PDT
was first used to treat skin lesions and then tested in cancers of the breast, central nervous
system, head and neck, lung, esophagus, cervix, bladder and prostate. Clinical studies
have been done using PDT for prostate cancer but its use remains experimental. Given
the preclinical demonstration of tumor destruction and clinical evidence suggesting a fa-
vorable side effect profile, Vascular-targeted Photodynamic Therapy (VTP) is now also
being explored in phase II trials for the preliminary treatment of localized prostate cancer.
These ongoing and future trials will define the role of VTP in the treatment of prostate
cancer.
12.4 High Intensity Focused Ultrasound (HIFU)
In HIFU treatment a convergent beam of high intensity ultrasound is emitted by a highly
focused piezocomposite transducer in shots lasting a few seconds. The sudden and intense
absorption of the ultrasound beam at the focal point provokes a sharp temperature increase
(about 85°C) that causes irreversible necrosis of tissue in the target area. Ultrasound en-
ergy is tightly focused, absorbed and converted to heat, resulting in a sharp delineation
between ablated and undamaged tissue. Accordingly, hundreds of cycles are often required
for complete treatment. The size and location of the ablated area is modifiable based on
the focusing system, ultrasound frequency, and the duration and absorption coefficient of
the tissue.
HIFU has been used for cancers of the liver, kidney, pancreas and breast, and as treatment
for uterine fibroids using MR guidance. However, its most widely studied application is
for prostate cancer. Using general or regional anesthesia and a transrectal probe equipped
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with a cooling device, real-time ultrasound visualization monitors the treatment effect.
Limitations include difficulty in treating the anterior prostate or smaller prostates and a
lack of long-term data. One of 2 systems is typically used, the Ablatherm® or Sonablate®
500.
HIFU has generally been intended for whole gland ablation, and early results with HIFU
appear encouraging in the context of study limitations for properly selected patients with
clinically organ confined disease. Since the overall experience is limited and follow-up is
immature, long-term cancer control rates and more comprehensive analyses of treatment
morbidity are necessary before advocating more widespread use of HIFU. Because HIFU
has been used predominantly as whole gland therapy, additional experience will determine
whether it can be successfully applied to focal lesions.
Magnetic resonance imaging is an outstanding modality for guiding placement of an inter-
ventional device into the prostate due to its excellent soft tissue contrast and multi-planar
capabilities. However, the greatest reason to use MRI to guide ultrasound ablation of the
prostate is its ability to quantify tissue temperature. MR thermometry yields images of
the maximum temperature reached during the treatment, the thermal dose, and the tem-
perature time product [105, 106, 107]. It has been recognized that the most significant
problem for in vivo MR thermometry has been its sensitivity to motion.
Once the treatment is done, the current gold standard to evaluate tissue viability is Con-
trast Enhanced (CE) MRI, in which tissue lacking perfusion appears as an area lacking
signal enhancement. CE-MRI provides an excellent delineation of the necrotic tissue. How-
ever, since it involves the administration of contrast materials, repeat use after a second
treatment is difficult due to the previously administrated contrast material that remains
in the tissue. In addition, it cannot differentiate between treated areas and preexisting
conditions such as cystic changes. For this reason, in this chapter I will explore the DWI
capability to assess tissue damage and cell death, without relocating the patient and the
applicators and without involving the administration of contrast agent.
The goals of this part of my thesis were to:
• optimize an EPI DWI sequence at 3T;
• demonstrate a drop in ADC similar to the one seen earlier in a previous study of the
group [106];
• investigate changes in ADC values before and after ablation.
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12.5 Methods
12.5.1 Experimental setup
A custom-made, high intensity ultrasound device was used to perform on 3 dogs trans-
urethral thermal ablation with MR thermometry based closed-loop feedback control in a
GE 3T scanner. The curvilinear applicator design utilized an array of two transducers
measuring 3.5mm×10mm (Fig. 12.1). The radius of curvature across the short axis of
Figure 12.1. a) Schematic drawing of the distal end of the curvilinear transurethral ultra-
sound applicator. b) Applicator photograph.
the transducers was 15 mm and the operating frequency was 6.5 MHz. They were at-
tached using silicone and conformal coating to a rectangular parallelepiped brass fixture
(34×4.5×1.3 mm) with a window (25×3.5×0.3 mm) milled out of the brass for the trans-
ducers. A custom multilumen pebax catheter (50 cm×34 mm OD) (Danforth Biomedical
Inc., Santa Clara, CA) formed the shaft of the applicator. Water flow from the catheter
circulated within a thin walled polyester balloon (35×10 mm) that surrounded the brass
structure. The water in this balloon removed excess heat from the transducers, cooled
the urethra, and acoustically coupled the transducer to the tissue. The catheter assembly
could be rotated within the cooling balloon via the proximal end of the applicator. A
bladder retention balloon was attached to the tip of the applicator for proper positioning
[108]. In vivo heating experiments with the curvilinear applicator were performed in three
canine prostates using an open intervention MR system for guidance. Multiple single shot
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and two sweeping procedures were performed in the three prostates. The transverse MR
temperature profile at the end of one of the single sonications is shown in Fig 12.2. The
total treatment time for the ablation of half the prostate in average was 42 min. Self-made
(a) (b) (c)
Figure 12.2. MR temperature profiles at the end of single sonications for in vivo
canine prostates (different slices from the same dog). Yellow pixels represent
T=50°, orange T=55°, red=60°.
EPI-DWI sequences with background suppression (DWIBS) were performed before and
after the ablation to characterize water diffusion in prostate tissues. The most common
diffusion imaging strategy, based on single-shot echo planar imaging (EPI) acquisitions,
helps solve the motion problem but is prone to severe artifacts and geometric distortions
from the chemical shift and the susceptibility effects prevalent in the abdomen and pelvis.
Thus, in this project an alternative diffusion imaging strategy has been used. Different
variants of DWIBS exist, but the basic idea is common to all of them. First, low ADC
lipids are suppressed; second, DWI of the entire body or a region of interest is performed
with considerable (for tissue outside the CNS) diffusion attenuation to make the low ADC
structures stand out (eg, 500-1000 s/mm2), whereas the remainder of the other tissues
are suppressed; third, maximum intensity projections (MIPs) are computed at different
projection angles to improve lesion visibility and facilitate diagnostic utility; and, fourth,
an inverted gray scale is applied to the MIPs. That is, low ADC structures appear hy-
pointense, whereas regular background appears bright to resemble scintigraphic images.
The latter step is cosmetic and can be used depending on the preference of the interpret-
ing radiologist.
To compute ADC value, we used 12 b-factor from 0 to 3500 s/mm2 (0, 50, 100, 300, 500,
700, 1000, 1400, 1800, 2300, 2800, 3500), using a tetrahedral encoding scheme to increase
signal-to-noise (SNR) ratio.
Since b increases quadratically with the gradient strength, often more than one gradient
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axis is applied simultaneously to boost the net diffusion-encoding gradient for a given
echo time. A very effective encoding scheme is tetrahedral encoding which uses four en-
coding directions (g1 = [Gx Gy Gz]T ; g2 = [−Gx Gy Gz]T ; g3 = [Gx − Gy Gz]T ; and
g4 = [Gx Gy −Gz]T ) applied simultaneously at full strength to uniformly measure diffusion
in four different directions. All three gradient axes are turned on simultaneously leading to
an effective gradient that is
√
3Gi(i = x, y, z) . This scheme has proven useful to compute
isotropically diffusion-weighted images with little extra time but SNR increased by up to
a factor of about three compared to scans with encoding applied just along the princi-
pal gradient direction, i.e. along x, y, and z. However, because more effective gradients
are involved, tetrahedral encoding usually demonstrates more eddy current effects than
unidirectional encoding. Thus, when DWI scans with diffusion encoding along different
directions are combined to compute an isotropically diffusion-weighted image, the resultant
image will be blurred if the eddy current-induced distortions are not compensated.
12.5.2 Image Processing
Initially four averages were obtained at each b value, and direction, then the four directions
have been averaged to obtain one image for each b-values. Two ROIs were identified on
each ablated area on each prostate: a central area appearing darker on the DWI image
(yellow ROI in Fig. 12.3(c)) and an outer ROI appearing brighter on the DWI image
(cyan ROI in Fig. 12.3(c)). Even if studies have used a range of b-values assuming
a monoexponential model to describe the changing signal from the prostate associated
with an increasing diffusion gradient, there are some [109, 110] that have been assumed a
biexponential model to evaluate prostate diffusion changing. This model has been taken
from studies in the brain, indicating two components of diffusion in tissue, said “fast” and
“slow” [111]. These fast and slow components are believed to arise from extracellular and
intracellular diffusion processes, respectively, with slow diffusion also showing correlation
with cell membrane density [112].
In addition to the tissue ROIs, noise measurements were made from an ROI within the air
of the inflated balloon within the rectum, demonstrated above 4.4. The signal vs b- factor
from each ROI, as extracted from the mean data sets were fit with both monoexponential
functions and biexponential decay functions of the form:
S = Aexp(−bDa) +Bexp(−bDb) (12.1)
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(a) (b)
(c) (d)
Figure 12.3. a) DWI image at b-value 700 s/mm2 obtained before the ablation. b) DWI
image at b-value 700 s/mm2 obtained after the ablation. White arrows point the ablated
region, where it is visible a darker central area surrounded by a brighter area. Two ROIs
are drawn on this regions (c). d) H&E image obtained after prostatectomy.
where S is the signal intensity, b the b- factor, Da and Db the fast and slow diffusion
coefficients, respectively, and A and B their amplitudes with the fraction of the fast dif-
fusion component given by A/(A + B). Fits were performed with a Marquardt-Levenberg
algorithm as implemented in Matlab software (The MathWorks, Inc., Natick, MA). The
fits of the data to monoexponential decay curves (B = 0 in Eq 12.1)) were performed in
order to allow for a comparison to determine whether the biexponential model provided
a statistically improved fit over the monoexponential model. Finally histology with H&E
was performed.
12.6 Results
This preliminary results suggested that, if a single b-value is to be obtained to monitor
the HIFU treatment, the preferred is 700 s/mm2, as this gives the highest CNR between
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ablated and non-ablated tissue, in fact this b-value has a signal intensity decreasing com-
parable to 1000 and 1400, but a higher SNR (Table 12.2). Moreover, in this study we
Table 12.2. Mean differences on 3 dogs between signal intensity before and after ablation.
SNR computed for each b-value
b-value Signal
differences
between pre
and post
ablation
SNR
0 26.09
50 5.56% 27.90
100 -0.54% 26.59
300 -10.70% 23.11
500 -16.68% 19.98
700 -18.63% 15.84
1000 -18.95% 11.69
1400 -18.18% 8.44
1800 -15.83% 6.92
2300 -13.53% 5.23
2800 -12.18% 4.75
3500 -10.74% 4.525
demonstrated that the biexponential model fits the data with a mean R2 = 0.998, thus
better than the monoexponential fit (R2 = 0.967) (Fig 12.4). A bi-exponential decay of
the signal increasing the b-values, suggesting the presence of two different type of diffusion,
said fast and slow, who change in rate and fraction after thermal ablation. Eq. 12.2 and
12.3 show the mean fitting parameters obtained in the three dogs.
Central yellow ROI (Fig. 12.3(c))
Spre_ablated = 0.71e
−bn2.71 + 0.28e−bn0.83
Spost_ablated = 0.49e
−bn2.57 + 0.49e−bn0.40
(12.2)
Outer blue ROI (Fig. 12.3(c))
Spre_ablated = 0.73e
−bn2.60 + 0.26e−bn0.71
Spost_ablated = 0.48e
−bn2.35 + 0.50e−bn0.34
(12.3)
After ablation, there is a shift from fast to slow diffusion. In addition, each diffusion
coefficient decreases after ablation, with the slow component decreasing more than the fast
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Figure 12.4. Signal decay representing the fitting of real data acquired on one dog
with monoexponential model (yellow line), biexponential model (red line) and a mo-
noexponential + a constant model. The last model should be represent a noise signal
presents in all the dataset.
component. Finally, histology indicated two histologically different areas: a central core,
where glands appeared to be intact, hence the name heat-fixed, surrounded by coagulative
necrosis without heat fixation. These two areas match the two ROIs different areas visible
in DWI images post ablation, indicating a different diffusivity according to the histological
conditions (Fig. 12.5).
12.7 Discussion
This preliminary study demonstrates changes in the fast and slow diffusion rates and
fractions after thermal ablation, suggesting the possibility to use DWI to monitor focal
treatment, without contrast injection and without relocating the patient. In addition, this
study showed differences in the diffusion rates in heat fixed vs. non-heat fixed ablated
tissue.
130
12 – Monitoring local treatment using Diffusion Weighted MR Imaging
(a) (b)
(c) (d)
Figure 12.5. a)CE-MRI image acquired after the ablation, manually registered to the histo-
logical image. b) Histology of the ablated area; the black arrow points the heat fixed area. c)
Haematoxylin Eosin (H&E) fixed image of the ablated prostate; the brighter area indicates
damaged cells. d) The ROIs previously drawn on the DWI image manually superimposed to
the H&E fixed image. Registration was manually performed between DWI and H&E image;
matching between the two ROIs and the histologically different areas is clearly visible.
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Conclusions
In conclusion, advantages of this innovative workup for prostate cancer are summarized as
follows:
1 CAD system using multispectral MRI could allow to diagnose PCa with a higher
accuracy than current tests, distinguishing areas within the gland with cancer from
those with normal or fibrous tissue. In this way, individuals with high PSA values
and a negative CAD-MR exam could avoid core-biopsies, thus reducing anxiety, the
diagnostic delay of a false-negative finding, procedure related complications and the
adverse events linked to over-treatment.
2 In case of a positive finding, CAD-MR could be used to perform biopsy under MR
guidance increasing the accuracy of the procedure. Furthermore, biopsy could allow
us not only to confirm the diagnosis of PCa but also possibly to identify tumor areas
having a different grading.
3 Imaging guided procedures, such as cryotherapy or MR guided High Intensity Fo-
cused Ultrasound (MRgFUS) could be performed having accurate color parametric
3D maps of the tumor available to plan treatment. MR can monitor temperature
and DWI can assess the success of the treatment by measuring the necrosis within
the area of treatment if the procedure is performed directly in the MR unit, as is the
case of MRgFUS.
However, all the steps here presented (registration, lesion detection) need to be unified
in a sole stand-alone system, as it has been done for the breast CAD system, in order
to validate the CAD in a larger dataset. If the CAD system will be sufficiently accurate
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in a laboratory setting we will conduct a prospective feasibility clinical trial to assess its
new role in the diagnostic work-up of patients with PCa. It is our intention to promote a
multicenter study, if the preliminary trial is successful.
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